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The mitochondrial carrier family is a group of transport proteins that are mostly localized 
to the inner mitochondrial membrane where they facilitate the movements of various 
solutes across the membrane. Although these carriers represent potential targets for 
therapeutic application, research on the mitochondrial carrier family has not progressed 
commensurately. The ADP/ATP carrier is the most studied of mitochondrial carriers and 
is referred to as the paradigm of the family. Since it was first reported about two decades 
ago, a long-standing mystery in the field is how the absence of the major mitochondrial 
ADP/ATP carrier in yeast, Aac2p, results in a specific defect in cytochrome c oxidase 
(COX; complex IV) activity. In light of the recent demonstration that Aac2p physically 
associates with respiratory supercomplexes (RSCs), the possibility emerged that the 
activity of the complex may be dependent on its association with Aac2p. Therefore, this 
work was done to understand the mechanism of regulation of complex IV activity by the 
ADP/ATP carrier in yeast (Saccharomyces cerevisiae). By using a transport-dead 
pathogenic AAC2 point mutant discovered in a patient with hypertrophic cardiomyopathy 
and mild myopathy, we sought to determine whether the reduced COX activity is due to 
absence of the interaction between Aac2p and components of the respiratory chain and/or 
the absence of Aac2p function (ADP/ATP transport). Using a battery of biochemical and 
molecular biology techniques, we uncovered a translation-dependent regulation of 
cytochrome c oxidase biogenesis that is provided by Aac2p function. Importantly, the 
steady state levels of mitochondrial genome-encoded complex IV subunits, which form the 
catalytic core of the complex, are significantly reduced when Aac2p function is missing, 
irrespective of the status of its association with respiratory supercomplexes. This decrease 
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in COX subunit amounts is not caused by a reduction in the mitochondrial DNA copy 
number or the level of its transcripts and does not reflect a defect in complex IV assembly. 
Instead, the absence of Aac2p activity results in an aberrant pattern of the mitochondrial 
translation. These results point to a direct functional link between Aac2p mediated 
transport and normal mitochondrial translation that is critical for the biogenesis of 
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The Mitochondrial Carrier Family: Emerging Roles in the Biogenesis of  





1.1 SOLUTE CARRIER FAMILY (SLC) 
Transport of substrates across biological membranes between and among 
organelles is an important feature of eukaryotic cells.  The SoLute Carrier (SLC) family, 
the second largest family of membrane proteins, is a large group of membrane transport 
proteins; in humans, there are 456 known members that are grouped into 65 subfamilies 
(Höglund, Nordström, Schiöth, & Fredriksson, 2011; Perland & Fredriksson, 2017). SLCs 
allow the movement of solutes—such as amino acids, ions, nucleotides, sugars and drugs—
across biological membranes. The family includes functionally related proteins that allow 
transport and exchange of solutes across cell membranes. Transport can be facilitative by 
simply allowing solutes to move across a membrane according to their relative gradient on 
either side. Additionally, SLCs can mediate secondary active transport by coupling the 
downhill flow of a substrate, typically an ion, to the uphill movement of another substrate 
against its relative gradient across a membrane.  Primary active transporters, ion channels 
and aquaporins are not included in the SLC family. The SLC family is structurally diverse 
as the criterion for inclusion in its ranks is being an integral membrane protein that 
transports a solute. However, within an individual family, members often share more than 
20% sequence homology (Hediger et al., 2004). Table 1.1 describes the current list of SLC 
family members based on http://slc.bioparadigms.org and the references that review each 
subfamily. Families SLC53-65 are newly registered, and are based on a work presented at 
the BioMedical Transporters 2017 conference in Lausanne, Switzerland. 
1.2 MITOCHONRIAL CARRIER FAMILY (SLC25) 
Across the inner mitochondrial membrane, the Solute Carrier 25 (SLC25) family 
of transporters transport solutes into and out of the mitochondrion, although a number of 
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the members of this family are localized to other cellular organelles such as chloroplasts 
and peroxisomes (Bedhomme et al., 2005; Visser, van Roermund, Waterham, & Wanders, 
2002). The mitochondrial carrier family (MCF) is the largest SLC subfamily and all 
members are encoded by the nuclear genome. As such, they are synthesized by cytoplasmic 
ribosomes and need to be imported from the cytosol to their final location. 35 members 
have been identified in yeast, 58 members in Arabidopsis thaliana, and 53 members have 
been identified in humans with about a third of these orphanized with no substrate(s) yet 
identified, as summarized in Table 1.2 (F. Palmieri & Pierri, 2010). Tissue distribution can 
vary from ubiquitous expression (e.g. SLC25A6 (Stepien, Torroni, Chung, Hodge, & 
Wallace, 1992)) to tissue-specific expression (e.g. SLC25A31 (Dolce, Scarcia, Iacopetta, 
& Palmieri, 2005; Rodić et al., 2005)).  
SLC25 members are generally characterized by the presence of a tripartite structure 
(Figure 1.1) of approximately 300 amino acids, six conserved transmembrane regions, and 
the three-fold repeated MCF signature motif, P-X-[DE]-X-X-[RK]. Although they vary in 
size and nature of shuttled substrates, most members catalyze the exchange of one solute 
for another (antiport), couple the transport of one solute with another (symport), or 
facilitate the transport of a solute (uniport). Because of their sequence similarity, it is 
assumed that the transport mechanism is similar for the extended family. 
1.2.1 Physiology of MCF 
MCF is a family of functionally diverse proteins. Members transport a wide range 
of solutes across the inner mitochondrial membrane (IMM) and are important bridges 
linking many biochemical pathways in the cytosol and the mitochondrial matrix (F. 
Palmieri, 2014).  Solutes transported include protons, nucleotides, amino acids, carboxylic 
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acids, inorganic ions, and cofactors. Their fundamental role in enabling metabolic 
compartmentalization cannot be overemphasized. SLC25 family members are involved in 
metabolic pathways such as heme synthesis and metal homeostasis (SLC25A28, 
SLC25A37, SLC25A38), fatty acid metabolism (SLC23A1, SLC25A20), amino acid 
metabolism (SLC25A13, SLC25A18, SLC25A22), nucleic acid metabolism (SLC25A19, 
SLC25A26, SLC25A33, SLC25A36), urea production (SLC25A2, SLC25A15) (LeMoine 
& Walsh, 2015; Shayakul, Clémençon, & Hediger, 2013; Shayakul & Hediger, 2004), 
oxidative phosphorylation (SLC25A3, SLC25A4, SLC25A5, SLC25A6, SLC25A31) and 
heat generation (SLC25A7, SLC25A9). In the next two sections, the physiology of select 
SLC25 members is briefly discussed to illustrate the diversity of cellular functions in which 
its members participate.  
1.2.1.1 Mitoferrins are fundamental to Iron transport 
Mitochondria are highly involved in the regulation of cellular iron. Iron is essential 
for mitochondrial function (Levi & Rovida, 2009). It is important in the heme biosynthetic 
pathway in the reaction step of ferrous iron incorporation into protoporphyrin IX catalyzed 
by ferrochetalase (Ponka, 1997). Heme is needed for synthesis of the mitochondrial 
cytochromes which are electron carriers critical for OXPHOS. In addition, iron-sulfur 
cluster biogenesis occurs in the mitochondrial matrix and is tightly linked to many other 
cellular processes such as heme biosynthesis, ribosome assembly, DNA synthesis, and 
translation initiation (Lill, 2009; Lill & Mühlenhoff, 2008). SLC25A28 and SLC25A37 
encode Mitoferrin 2 (MFRN2) and Mitoferrin 1 (MFRN1), respectively, which are 
involved in iron import into the mitochondrion. In zebrafish and mammals, MFRN1 is 
expressed predominantly in hematopoietic tissues whereas MFRN2, with 65% amino acid 
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identity to its paralog is widely expressed (Amigo et al., 2011; Shaw et al., 2006). MFRN2 
has about 38% identity to Mrs3p and Mrs4p (Shaw et al., 2006), two yeast transporters 
originally identified as suppressors of an intron splicing defect (Waldherr et al., 1993) that 
have since been associated with iron transport (Foury & Roganti, 2002). Yeast lacking 
Mrs3p and Mrs4p exhibit poor growth in iron-depleted conditions (Foury & Roganti, 
2002). MFRN1 loss of function of in mice and zebrafish results in reduced iron uptake into 
mitochondria and defective hemoglobinization (Shaw et al., 2006). Using 3T3 fibroblasts 
and mouse embryonic stem cells, it was shown that MFRN2 and MFRN1 are both involved 
in mitochondrial iron uptake in non-erythroid cells (Paradkar, Zumbrennen, Paw, Ward, & 
Kaplan, 2009). Heme synthesis is extremely compromised when both transporters are 
silenced and overexpression of one can functionally compensate for the loss of the other in 
non-erythroid cells (Paradkar et al., 2009). These results indicate the fundamental 
importance of these proteins in mitochondrial iron metabolism in erythroid and non-
erythroid cells. 
1.2.1.2 UCPs provide a pathway for proton leakage   
The uncoupling proteins (UCPs) are regulated mitochondrial proteins known to 
transport protons, anions or other mitochondrial substrates (Fedorenko, Lishko, & 
Kirichok, 2012; Jezek, Jabůrek, & Garlid, 2010; Monné et al., 2018; Porter, 2012). Six 
UCP homologues have been discovered in humans - UCP1 or thermogenin (Heaton, 
Wagenvoord, Kemp, & Nicholls, 1978), UCP2 (Fleury et al., 1997), UCP3 (Boss et al., 
1997), UCP4 (Mao et al., 1999), UCP5 or BMCP1 for brain mitochondrial carrier protein 
1 (Sanchis et al., 1998), and UCP6 or KMCP1 for kidney mitochondrial carrier protein 1 
(Haguenauer et al., 2005). UCPs uncouple OXPHOS from ATP synthesis; they dissipate 
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proton gradients by allowing protons that have been pumped into the intermembrane space 
by respiratory complexes to flow back into the mitochondrial matrix without being utilized 
for ATP synthesis. The translocation of hydrogen ion by UCPs requires fatty acids and this 
activity is inhibited by purine nucleotides such as GDP. However, there is controversy 
regarding the role of fatty acids in activating the uncoupling process that is directly 
pertinent to the putative UCP transport mechanism. There are currently two models of how 
UCP transports protons and anions in a process that involves or is regulated by fatty acids, 
as extensively reviewed (Jezek, Holendová, Garlid, & Jaburek, 2018). According to the 
fatty acid cycling mechanism, UCPs carry protons across the IM bound to fatty acids, 
which are flipped between membrane leaflets and subject to protonation and deprotonation 
events that in the net dissipate the proton gradient (Jabůrek, Varecha, Jezek, & Garlid, 
2001; Jezek et al., 2018; Jezek et al., 2010; Jezek, Modrianský, & Garlid, 1997a, 1997b; 
Kamp & Hamilton, 1992; Kamp, Hamilton, & Westerhoff, 1993; Kamp, Zakim, Zhang, 
Noy, & Hamilton, 1995). This model is validated by a nuclear magnetic resonance and 
functional mutagenesis studies on UCP2 which provided molecular and structural support 
for this protonophoretic model (Berardi & Chou, 2014). The other mechanism, referred to 
as the fatty acid shuttling-carrier mechanism, has recently been experimentally disproven 
(Jezek et al., 2018). According to this model, originally advanced following a patch clamp 
study on UCP1 (Fedorenko et al., 2012), the protonated fatty acid must remain bound by 
hydrophobic interactions with UCP and shuttle hydrogen ion across the inner 
mitochondrial membrane through the protein (Jezek et al., 2018). 
UCP1 is thought to be exclusively found in brown adipose tissue and is the only 
UCP responsible for adaptive adrenergic non-shivering thermogenesis (Golozoubova et al., 
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2001; Matthias et al., 2000; Nicholls, Bernson, & Heaton, 1978; Porter, 2008). As such, it 
is firmly established that UCP1 functions as a true uncoupling protein that utilizes the 
electrochemical gradient produced by the respiratory chain to produce heat instead of ATP. 
Also, there seems to be a close relationship between mitochondrial reactive oxygen species 
(ROS) and UCP1-dependent thermogenesis although whether or not superoxide modulates 
UCP1 function is debated (Chouchani, Kazak, & Spiegelman, 2017; Echtay et al., 2002; 
Silva et al., 2005). Nonetheless, work with ucp1 knockout (ucp1-/-) mice has established 
that UCP1 is a target of redox modification in vivo (Chouchani et al., 2016). A recent study 
showed that brown adipose tissue (BAT) from ucp1-/ mice have reduced respiratory chain 
proteins and increased host defense signaling following exposure to cold (Kazak et al., 
2017). Intriguingly, BAT-derived mitochondria from ucp1-/- mice are more sensitive to 
calcium overload in a ROS-dependent manner (Kazak et al., 2017). Thus, though UCP1 is 
traditionally linked to thermogenesis, it is very clear that UCP1 function extends beyond 
thermogenesis. 
UCP2-5 are not involved in thermogenesis even though they provide mild 
uncoupling which may be protective against oxidative stress (Jezek et al., 2018). UCP2 is 
widely expressed (Fleury et al., 1997; Gimeno et al., 1997) and has numerous 
pathophysiological roles. For instance, due to its ability to reduce reactive oxygen species 
generation, UCP2 participates in both host immunity and the inflammatory response 
(Arsenijevic et al., 2000; Mattiasson & Sullivan, 2006; Nègre-Salvayre et al., 1997). In 
addition, UCP2 has been implicated in body mass regulation, glucose metabolism, and 
carcinogenesis (Derdak et al., 2008; Horimoto et al., 2004; Li, Nichols, Nathan, & Zhao, 
2013; Li et al., 2015; Mattiasson & Sullivan, 2006; Sreedhar, Petruska, Miriyala, 
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Panchatcharam, & Zhao, 2017; Vozza et al., 2014; C. Y. Zhang et al., 2001). UCP3 is 
expressed mainly in the skeletal muscle and brown adipose tissue, and minimally in the 
heart (Boss et al., 1997; A. Vidal-Puig, Solanes, Grujic, Flier, & Lowell, 1997) where it is 
important for ROS attenuation but not body mass regulation or fatty acid metabolism (A. 
J. Vidal-Puig et al., 2000). Indeed, mitochondria from mice with lower levels of UCP3 
have increased ROS production and oxidative damage further suggesting that UCP3 
protects against ROS and oxidative damage (Brand et al., 2002). UCP4 is predominantly 
expressed in the nervous system including different regions of the brain, the spinal cord, 
hair cells of the inner ear, and Merkel cells in the skin (Liu et al., 2006; Smorodchenko, 
Rupprecht, Fuchs, Gross, & Pohl, 2011; Smorodchenko et al., 2009). UCP4 overexpressing 
neuronal cell lines have reduced oxidative phosphorylation with a corresponding increase 
in glucose uptake and glycolysis (Liu et al., 2006). These metabolic changes correlate with 
a drop in ROS production, a reduced tendency for calcium overload and an overall 
increased resistance to apoptosis (Liu et al., 2006). Overexpression of UCP4 in pre-
adipocyte cell lines stimulates their proliferation, inhibits their differentiation into 
adipocytes and protects them against apoptosis (M. Zhang et al., 2006). Furthermore, 
impaired insulin sensitivity and mitochondrial biogenesis, decreased mtDNA level and 
increased ROS production occurs in adipocyte cell lines overexpressing UCP4 suggesting 
a global negative impact of UCP4 on mitochondrial function (Gao et al., 2010). However, 
in UCP4 overexpressing L6 myocytes, insulin sensitivity was improved with no change in 
intracellular ROS production, mtDNA levels or mitochondrial biogenesis (Gao et al., 
2011). Regulated UCP4 expression, therefore, seems to be critical for optimal 
mitochondrial and cellular function. 
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UCP5 is expressed principally in the central nervous system and has three different forms 
(long form, UCP5L with 325 amino acids; short form, UCP5S with 322 amino acids; and 
short insert form, UCP5S1 with 353 amino acids) (Ramsden et al., 2012). UCP5 
overexpression in human SH-SY5Y cells increases proton leak, reduces mitochondrial 
membrane potential and ATP production and increases oxygen consumption (Kwok et al., 
2010). UCP6 has not been well studied. To date, it is associated with carcinogenesis 
(Nohara et al., 2012) and its expression in the kidney cortex is increased following pro-
oxidant states (Haguenauer et al., 2005). 
1.2.2 Pathology of MCF 
MCF provide substrates for various biochemical processes in the cell. Consistent 
with their diverse and fundamental roles in metabolism, the absence or dysfunction of 
assorted MCF family members are associated with a wide variety of disorders including 
hematologic, neurologic, and cardiac diseases. Underlying many of these disorders is a 
defect in OXPHOS leading to disturbed mitochondrial energy metabolism that manifests 
in a wide variety of clinical signs and symptoms. A number of systemic diseases caused 
by SLC25 members is discussed briefly and Table 1.3 displays a summary of MCF-
involved diseases clustered by presentation.   
Mitochondrial carriers encoded by SLC25A28, SLC25A37, and SLC25A38 are 
important for heme synthesis which requires cellular iron, glycine and succinyl CoA 
(Figure 1.2). Since red blood cells are very sensitive to defects in heme synthesis, 
dysfunction in any of these mitochondrial carriers causes anemia (Xu, Barrientos, & 
Andrews, 2013). The erythroid specific SLC25A38, which based on its requirement for 
erythropoiesis was initially predicted to encode an amino acid carrier capable of 
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transporting glycine, is now regarded as a glycine transporter (Fernández-Murray et al., 
2016; Guernsey et al., 2009; Lunetti et al., 2016). Pathogenic mutations in SLC25A38 and 
knockdown experiments in zebrafish implicate the carrier in the etiology of congenital 
sideroblastic anemia (Guernsey et al., 2009) (OMIM 610819). Mutations in the carrier are 
the second most common cause of inherited sideroblastic anemia and may account for 
about a fifth of all cases (Harigae & Furuyama, 2010; Horvathova, Ponka, & Divoky, 
2010). As previously discussed, SLC25A28 and SLC25A37, which encode the mitoferrins, 
are critical for iron homeostasis. Although no human mutations have been described for 
these carriers, MFRN1 has been shown to be important for heme synthesis in erythroid 
cells (Shaw et al., 2006). 
SLC25A46 encodes a novel outer mitochondrial membrane protein, is widely 
expressed in the nervous system (Haitina, Lindblom, Renström, & Fredriksson, 2006), and 
mutated numerous neurological diseases including optic atrophy spectrum disorder, 
Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia, and lethal 
congenital pontocerebellar hypoplasia (Abrams et al., 2015; Terzenidou et al., 2017; Wan 
et al., 2016) (OMIM 610826). Insight into each of these neurological diseases is hampered 
by the fact that SLC25A46 is also an orphan member of the MCF whose substrate(s) has 
not been defined (F. Palmieri & Monné, 2016). However, given its unusual localization to 
the outer membrane, whether SLC25A46 functions as a transporter or instead has novel 
activities that are unrelated to its SLC25 membership remains an open question. 
Mitochondrial energy production is high in cardiac tissue and it is unsurprising that 
many mitochondrial carriers have been associated with cardiac disease, manifested in most 
cases as hypertrophic cardiomyopathy. Mutations in SLC25A4 (aka adenine nucleotide 
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translocase-1; ANT1) are responsible for both the autosomal dominant and recessive 
cardiomyopathic type mitochondrial DNA depletion syndromes (OMIM 617184 and 
615418 respectively) (Echaniz-Laguna et al., 2012; Körver-Keularts et al., 2015; L. 
Palmieri et al., 2005; Thompson et al., 2016),. Mutations in SLC25A3 that encodes the 
phosphate carrier (PiC) cause either hypertrophic cardiomyopathy and impaired function 
of other organs such as skeletal muscle (Mayr et al., 2007; Mayr et al., 2011) or isolated 
cardiomyopathy (Bhoj et al., 2015). Interestingly, in the latter case (Bhoj et al., 2015), the 
mutations discovered in SLC25A3 were a mix of a single nucleotide change and a stretch 
of indels, both of which could potentially impact the two mammalian isoforms of the 
protein (Bhoj et al., 2015; Seifert, Ligeti, Mayr, Sondheimer, & Hajnóczky, 2015). 
Carnitine-acylcarnitine translocase deficiency resulting from many different mutations in 
SLC25A20 results in a multi-systemic disorder that includes cardiomyopathy as one of its 
clinical features (OMIM 212138)  (Iacobazzi et al., 2004; Pande et al., 1993; Stanley et al., 
1992). A genome-wide association study reported an association between UCP5 gene 
variants and the formation of atherosclerotic plaques suggesting that UCP5 has a protective 
role against atherosclerosis (Dong et al., 2011).  Furthermore, UCP5 expression is 
increased in embolic stroke and multiple infarction brain lesions probably due to 
upregulation brought about by chronic ischemic stress (Nakase, Yoshida, & Nagata, 2007). 
However, since UCP5, like SLC25A38 and SLC25A46, is an orphan MCF, the underlying 
pathogenic mechanism is very much unclear at this time. 
1.2.3 Challenges to Research on MCF 
Mitochondrial carriers, and solute carriers in general, perform a central role in 
metabolism and their association with a myriad of diseases makes them attractive 
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candidates for basic and translational research. However, it has been noted that this area of 
research has not grown in commensurate proportion to its size or the potential gold mine it 
affords (César-Razquin et al., 2015). Most of these carriers are yet to be fully characterized 
and many of them remain totally uncharacterized. A number of technical factors have 
hampered growth of research focused on the extended membership of the SLC family that 
of course includes the MCF. A huge technical hurdle is the systemic absence of validated 
antibodies specific to most of these proteins. Further, many of the available antibodies are 
too weak to detect endogenous proteins whose expression is likely low and in general, 
many of the available reagents have not been rigorously characterized and validated (e.g. 
absence of signal with appropriate negative controls such as knockout cells). Compounding 
issues is the fact that many SLC members appear to have low immunogenicity which likely 
stems from the fact that they are polytopic membrane proteins that often display high 
interspecies conservation. Finally, transport assays are tedious to perform and somewhat 
limited by the volume of substrates available and/or required to de-orphanize a SLC 
protein. 
Interestingly, a number of carriers have been shown to display substrate 
promiscuity by transporting more than one type of solute (Fiermonte, Paradies, Todisco, 
Marobbio, & Palmieri, 2009). Two members in Arabidopsis thaliana, AtUCP1 and 
AtUCP2, previously thought to be uncoupling proteins and therefore named as such were 
recently assigned the function of transporting amino acids, dicarboxylates, phosphate, 
sulfate, and thiosulfate (Monné et al., 2018). The Pi carrier in mammals, SLC25A3, was 
originally described as a phosphate symporter (Seifert et al., 2015; Wohlrab & Flowers, 
1982) whose mutation is associated with fatal childhood diseases (Bhoj et al., 2015; Mayr 
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et al., 2007). Pic2p, originally thought to be a second albeit minor Pi carrier in yeast, 
actually functions as a Cu++ transporter responsible for the import of copper, required for 
cytochrome c oxidase assembly, into the mitochondrial matrix (Vest, Leary, Winge, & 
Cobine, 2013). Similarly, SLC25A3, which shares 65% similarity with Pic2p, was recently 
shown to have a conserved role for copper transport in vivo and in vitro (Boulet et al., 2017; 
Vest et al., 2013).  
Apparent functional redundancy is another recurring feature of mitochondrial 
carriers (Taylor, 2017). For example, mitochondrial nucleotide homeostasis not only 
involves the ADP/ATP carriers (SLC25A4, SLC25A5, SLC25A6 and SLC25A31) but also 
is influenced by the ATP-Mg/Pi carriers (SLC25A23, SLC25A24, and SLC25A25). There 
is still a lot of unknowns regarding how all of these different transporters maintain the 
nucleotide pool across the inner mitochondrial membrane (IMM). It has been suggested 
that different mammalian ADP/ATP carrier isoforms, which do not transport AMP, may 
have different preferred transport modes i.e. ATP vs ADP. For instance, based on its high 
expression in cancer cells, SLC25A5 (also called adenine nucleotide translocase-2;  ANT2) 
was postulated to preferentially import ATP made by glycolysis, an activity that maintains 
the mitochondrial membrane potential and by extension, other essential mitochondrial 
functions (Chevrollier et al., 2005; Giraud, Bonod-Bidaud, Wesolowski-Louvel, & 
Stepien, 1998; Stepien et al., 1992). However, it was recently demonstrated in a range of 
cancer cells that the uptake of ATP is in fact completely independent of the activity of any 
ADP/ATP carrier isoform (Maldonado et al., 2016). As such, it remains unresolved 
whether the different ANT isoforms do or do not have distinct transport activities and/or 
substrate preferences. Also unclear is how the calcium-dependent ATP-Mg/Pi carriers, 
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which were originally thought to preferentially transport ATP but since demonstrated to 
also transport other adenine nucleotides (Fiermonte et al., 2004), interface with the 
ADP/ATP carriers to modulate mitochondrial nucleotide homeostasis. As research 
progresses in this area, the substrate(s) transported by many of these proteins will be 
identified which will provide foundational information as to their physiological roles.   
1.3 The ADP/ATP carrier protein 
Eukaryotic cells make energy in the form of ATP in the mitochondrial matrix and the ATP 
is translocated through the impermeable IMM to power many processes in the cell.  The 
ADP/ATP carriers (AAC) provide the means of transport of ATP and its precursor ADP, 
across the IMM. Under physiological conditions, 1 molecule of ADP from the cytosol is 
exchanged for 1 molecule of matrix-localized ATP by the activity of the ADP/ATP carrier. 
AAC, referred to as adenine nucleotide translocase (ANT) in humans, is a notable MCF 
member as it was the first to have its amino acid sequenced (Aquila, Misra, Eulitz, & 
Klingenberg, 1982) and its 3D structure solved (Pebay-Peyroula et al., 2003). Similar to 
all members of the MCF and regarded as a paradigm for this family, AACs are nuclear-
encoded, integral membrane proteins with approximately 300 amino acids arranged into 
three repeats linked by two loops on the cytosolic side. There are two transmembrane α-
helices in each repeat connected together by a long loop on the matrix side, giving the 
carrier a three-fold pseudosymmetry (F. Palmieri, 2013). 
One of the most abundant proteins in the IMM, AACs are encoded by multiple 
different genes in both unicellular and multicellular eukaryotes. There are three yeast AAC 
isoforms and four human ANT isoforms. The human ANT isoforms overlap in their 
expression pattern but exhibit tissue-specificity. ANT1 is the most equivalent to yeast 
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Aac2p and the predominant isoform in the heart and skeletal muscle (Stepien et al., 1992). 
ANT2 is mostly expressed in regenerative tissues such as the kidney and liver, ANT3 is 
ubiquitously expressed at low baseline levels, and ANT4 is selectively expressed in the 
testis (Doerner et al., 1997; Dolce et al., 2005; Dupont & Stepien, 2011; Kim et al., 2007; 
Rodić et al., 2005; Stepien et al., 1992). Aac2p is the most abundant of all three isoforms 
in yeast and the only one absolutely required for oxidative phosphorylation and growth on 
respiratory carbon sources (Lawson, Gawaz, Klingenberg, & Douglas, 1990). Aac1p and 
Aac3p are minor isoforms in yeast that under normal growth conditions, are undetectable 
at the protein level. Aac1p expression is repressed in hypoxic conditions (Gavurníková, 
Sabova, Kissová, Haviernik, & Kolarov, 1996) and Aac3p expression is induced in 
anaerobic situations (Sabová, Zeman, Supek, & Kolarov, 1993).  
AAC has been a subject of many controversies in the field of mitochondrial 
biology. First, the oligomeric status of the OXPHOS machinery has been much debated 
over the past 18 years. Originally thought to consist of individual complexes in a functional 
chain, the advent of Blue-Native Polyacrylamide Gel-Electrophoresis (BN-PAGE) 
(Schägger & von Jagow, 1991), a gentle electrophoretic technique for analysis protein-
protein interactions, facilitated the discovery and ultimate acceptance that the respiratory 
complexes interact to form higher-order supramolecular complexes of varying 
stoichiometry that are referred to as respiratory supercomplexes (RSCs) (Acín-Pérez, 
Fernández-Silva, Peleato, Pérez-Martos, & Enriquez, 2008; Cruciat, Brunner, Baumann, 
Neupert, & Stuart, 2000; Gu et al., 2016; Letts, Fiedorczuk, & Sazanov, 2016; Moreno-
Lastres et al., 2012; Schägger & Pfeiffer, 2000; Wu, Gu, Guo, Huang, & Yang, 2016). The 
RSCs are conserved despite differences in composition across different species. For 
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example, in yeast which lack complex I, RSCs form composed of complexes III and IV 
whereas in mammals, RSCs consist of complexes I, III, and IV (Schägger & Pfeiffer, 
2000). Nevertheless, there is still some controversy as to their functional and physiological 
relevance. Recently it was demonstrated that the respiratory supercomplexes (RSC) are 
functional entities (Barrientos & Ugalde, 2013; Lapuente-Brun et al., 2013) whose 
structures have since provided novel insight into the potential benefits that they may confer 
(Althoff, Mills, Popot, & Kühlbrandt, 2011; Dudkina, Kudryashev, Stahlberg, & Boekema, 
2011; Genova & Lenaz, 2014; Gu et al., 2016; Letts, Fiedorczuk, & Sazanov, 2016; 
Schäfer, Dencher, Vonck, & Parcej, 2007; Wu, Gu, Guo, Huang, & Yang, 2016). 
Functional benefits of RSCs that have been suggested but not yet proven include: improved 
electron transfer efficiency and reduced ROS generation, each stemming from a substrate 
channeling based mechanism; increased metabolic flexibility resulting from changes in 
RSC composition; and finally, enhanced  stability and functionality of all participating 
complexes in the specific context of the protein-dense inner mitochondrial membrane 
(Barrientos & Ugalde, 2013; Milenkovic, Blaza, Larsson, & Hirst, 2017).   
About ten years ago, a new functional entity was shown to interact with yeast RSCs: 
Aac2p (Claypool, Oktay, Boontheung, Loo, & Koehler, 2008; Dienhart & Stuart, 2008). 
This association was recently shown to be evolutionarily conserved as two distinct human 
ANT isoforms also form complexes with RSCs (Lu et al., 2017). Functionally, this 
conserved interaction could benefit both RSCs and the AACs. Specifically, the electrogenic 
exchange of ATPin/ADPout by AAC/ANT is positively influenced by the membrane 
potential (ΔΨ) across the IM (Krämer & Klingenberg, 1980) which of course is established 
by the electron transport chain. Similarly, by dissipating the electrical gradient, productive 
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AAC/ANT transport makes it easier for RSCs to pump protons. As such, it is reasonable 
to hypothesize that this known functional synergy is further enhanced by being physically 
associated. Additional work is needed to test this provocative hypothesis. 
AACs interacts with the respiratory supercomplexes in the presence of cardiolipin, 
a unique phospholipid found exclusively in the mitochondrion (Claypool et al., 2008). 
Available structures of AAC/ANTs depict three tightly bound cardiolipin molecules per 
monomer (Beyer & Klingenberg, 1985; Pebay-Peyroula et al., 2003; Ruprecht et al., 2014). 
In the absence of cardiolipin, Aac2p function is impaired and Aac2p assembly is drastically 
altered (Claypool et al., 2008; Jiang et al., 2000). The absence of cardiolipin also 
destabilizes the RSCs (Pfeiffer et al., 2003; M. Zhang, Mileykovskaya, & Dowhan, 2002), 
including its association with Aac2p (Claypool et al., 2008). That Aac2p assembly and 
function is CL-dependent has led to the hypothesis that the assembly and function of 
AAC/ANTs may be the “Achilles heel” of a multitude of cardiolipin-based diseases 
(Claypool, 2009; Klingenberg, 2008). The structural changes in RSCs and Aac2p that occur 
in the absence of cardiolipin have clear functional consequences (Claypool et al., 2008). 
However, the relative contribution of each structural change— impaired assembly of RSCs, 
Aac2p, or RSC-Aac2p— that occurs in the absence of cardiolipin to the associated 
mitochondrial dysfunction has not been established. 
 It has also been hotly debated whether the protein exists and/or functions as a 
monomer or dimer. Mitochondrial carriers were originally accepted to exist and function 
as homo-dimers (Capobianco, Ferramosca, & Zara, 2002; Dyall, Agius, De Marcos Lousa, 
Trezeguet, & Tokatlidis, 2003; Klingenberg, 1981; Kotaria, Mayor, Walters, & Kaplan, 
1999; Lin, Hackenberg, & Klingenberg, 1980; Nury et al., 2005; Palmisano et al., 1998; 
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Postis, De Marcos Lousa, Arnou, Lauquin, & Trézéguet, 2005; Schroers, Burkovski, 
Wohlrab, & Krämer, 1998; Trézéguet et al., 2000). A number of studies, motivated by the 
crystal structures (Kunji & Harding, 2003; Pebay-Peyroula et al., 2003; Ruprecht et al., 
2014) have challenged this initial view. Using a variety of biochemical, biophysical and 
structural studies, the Kunji lab has provided evidence that AAC functions, and in fact 
exists in the IMM, as monomers (Bamber, Harding, Butler, & Kunji, 2006; Bamber, 
Harding, Monné, Slotboom, & Kunji, 2007; Bamber, Slotboom, & Kunji, 2007; Kunji & 
Crichton, 2010; Kunji & Harding, 2003). However, the functional significance of AACs 
interaction with the RSCs, whether the interaction occurs as monomeric or oligomeric 
units, what subunits of the respiratory complexes are involved in the interaction, and 
whether or not the RSCs facilitate AACs’ oligomerization are outstanding questions in 
need of experimental answers.   
The absence of Aac2p in yeast impairs oxidative phosphorylation (Claypool et al., 
2008; Dienhart & Stuart, 2008; Fontanesi et al., 2004; Heidkämper, Müller, Nelson, & 
Klingenberg, 1996; Müller, Basset, Nelson, & Klingenberg, 1996). Prior mutagenic studies 
of Aac2p suggested that the OXPHOS machinery is dependent on Aac2p function and/or 
expression (Müller et al., 1996; Müller, Heidkämper, Nelson, & Klingenberg, 1997). More 
recently, several groups, including ours, reported similar findings of specific reduction in 
cytochrome c oxidase activity in yeast strains lacking Aac2p (Claypool et al., 2008; 
Dienhart & Stuart, 2008; Fontanesi et al., 2004; Heidkämper et al., 1996; Müller et al., 
1996). It remains to be determined, however, how the absence of Aac2p results in a specific 
defect in cytochrome c oxidase activity. Mechanistically, Aac2p nucleotide transport 
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activity and/or its interaction with the RSCs may be important for optimal cytochrome c 
oxidase activity. 
1.4 Mitochondrial translation 
The vast majority of mitochondrial proteins are translated in the cytosol and 
thereafter have to be imported into the mitochondrion. For those proteins encoded by the 
mitochondrial genome (mtDNA), mitochondria have retained a dedicated, dual-origin 
translational machinery whose architecture is similar to that of bacteria. Consistent with 
this bacterial origin, mitochondrial translation is pharmacologically unaffected by 
cycloheximide, an inhibitor of cytosolic translation, and is instead sensitive to antibiotics 
such as puromycin. Eight polypeptides in yeast and thirteen polypeptides in humans are 
encoded by mtDNA and produced via mitochondrial translation. Apart from genes for these 
polypeptides, the mtDNA also encodes a set of transfer (t)RNAs, ribosomal (r) RNAs and 
in yeast, the RNA component of the mitochondrial RNAse P (Towpik, 2005; Walker & 
Engelke, 2008). The mitochondrial translational cycle is subdivided into four steps— 
initiation, elongation, termination and recycling—and nuclear encoded polypeptide factors 
are required at different steps for optimal mitochondrial translation (Kehrein, Bonnefoy, & 
Ott, 2013; Smits, Smeitink, & van den Heuvel, 2010; Towpik, 2005). An example of a 
nuclear-encoded factor in yeast is the mitochondrial translation initiation factor 3 (mIF3p), 
the Saccharomyces cerevisiae homolog of the bacterial translation initiation factor 3 (IF3). 
Its function is conserved and overlaps with human mIF3p (Atkinson et al., 2012; 
Kuzmenko et al., 2014), and its absence in yeast disrupts mitochondrial translation 
(Kuzmenko et al., 2016). In addition, a number of translational activators directly 
interacting with mRNAs of mitochondrial encoded polypeptides are necessary to optimize 
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the translation of a specific mtDNA-encoded polypeptide e.g. synthesis of Cox1p is 
affected when Mss51p is absent or limiting (Barrientos, Zambrano, & Tzagoloff, 2004; 
Fontanesi, Clemente, & Barrientos, 2011; Perez-Martinez, Broadley, & Fox, 2003; Perez-
Martinez, Butler, Shingu-Vazquez, & Fox, 2009; Siep, van Oosterum, Neufeglise, van der 
Spek, & Grivell, 2000). 
Translation of mitochondrial proteins is tightly coupled to their assembly into 
respiratory complexes in a manner similar to a mechanism described as “controlled by 
epistasy of synthesis” (CES) that exists in the biogenesis of photosynthetic protein 
complexes (Choquet et al., 2001; Towpik, 2005). For example, in yeast, Cox1p synthesis 
is tightly coupled to the assembly of respiratory complex IV which helps to balance the 
production of subunits with their assembly into the holoenzyme which in the net preserves 
mitochondrial proteostasis (Barrientos et al., 2004; Perez-Martinez et al., 2003; Soto, 
Fontanesi, Liu, & Barrientos, 2012; Towpik, 2005). 
1.5 Emerging Roles in the Biogenesis of Cytochrome c oxidase 
In yeast and in humans, there is an emerging link between the function of MCF 
members and cytochrome c oxidase biogenesis. For instance, it was shown that a 
destabilizing pathogenic mutation in SLC25A46 impairs OXPHOS and Ascorbate/TMPD-
dependent respiration and reduces steady state levels of complex IV subunits (Janer et al., 
2016). These findings are consistent with a complex IV-specific assembly defect in 
SLC25A46 mutant fibroblasts. At present, the mechanistic basis for the reduced steady state 
levels of complex IV subunits has not been determined. While it is not totally unexpected 
that MCF carriers play a role in the assembly of this intricate complex with subunit derived 
from two genomes (many SLC members provide substrates that serve as building blocks 
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needed for processes such as mitochondrial DNA replication, transcription, translation, 
and/or post-translational assembly of protein complexes), it is very surprising that these 
defects seem to specifically impact complex IV without significantly affecting the other 
OXPHOS complexes that are built from subunits expressed from both the nuclear and 
mitochondrial genomes.  
Very recently, the yeast ortholog of the human SLC25A38, HEM25, important for 
heme synthesis as a mitochondrial glycine importer, was tested for its role in the stability 
of proteins of the respiratory complexes (Dufay, Fernández-Murray, & McMaster, 2017). 
Interestingly, while deletion of Hem25p compromises the steady state level of subunits of 
all the respiratory complexes except for complex V (ATP synthase), its absence is most 
detrimental on complex IV (Dufay et al., 2017). Intriguingly, the combined absence of 
Hem25p and Flx1p, the mitochondrial flavin adenine dinucleotide transporter (ortholog of 
human SLC25A32), further reduces the steady states level of subunits of the hem25Δ-
affected respiratory complexes except complex IV (Dufay et al., 2017). These results are 
consistent with a model that Hem25p and Flx1p provide heme and FAD, respectively, 
which are required for the assembly of the respiratory chain complexes.   
Furthermore, siRNA knockdown of the two isoforms of SLC25A3, SLC25A3-A and 
SLC25A3-B, in many different cell types results in reduced cytochrome c oxidase 
holoenzyme levels and activity (Boulet et al., 2017). When SLC25A3 is limiting, the steady 
state levels of COX4, a nuclear encoded subunit of cytochrome c oxidase, and 
mitochondrial copper are reduced (Boulet et al., 2017). Interestingly, COX4 abundance is 
rescued by copper supplementation (Boulet et al., 2017). Since copper is critical for the 
assembly of cytochrome c oxidase (Baile & Claypool, 2013; Diaz, 2010), defects in copper 
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import are likely to impair cytochrome c oxidase biogenesis. Nevertheless, SLC25A3 
function may be modulated and/or linked to the assembly of cytochrome c oxidase via a 
pathway that is presently unidentified (Boulet et al., 2017). 
Finally, the absence of Aac2p in yeast leads to a specific reduction of cytochrome 
c oxidase activity while the activity of complex III is unaffected (Dienhart & Stuart, 2008). 
The reduced complex IV activity likely stems from lower steady state levels of its subunits 
in the absence of Aac2p. These findings are consistent with the impaired OXPHOS activity 
that occurs when Aac2p expression is decreased or ablated (Claypool et al., 2008; 
Heidkämper et al., 1996; Müller et al., 1996; Müller et al., 1997). Intuitively, the 
mechanistic basis for the reduced steady state levels of complex IV subunits could derive 
from a defect in any step in its biogenesis that is regulated/modulated by and/or dependent 
on the nucleotide transport function of Aac2p. Alternatively, the conserved AAC/ANT-
RSC interaction may itself be critical for robust cytochrome c oxidase expression, 
assembly, and/or function.  Since the Aac2p and ANT1/ANT2 interactomes all included 
other SLC25 family members (Claypool et al., 2008; Lu et al., 2017), it is possible that 
these MCF-MCF interactions are critical for maintaining the abundance of metabolites that 
are needed for optimal mitochondrial translation and assembly of respiratory complexes. 
Future efforts focused on dissecting the functional significance of distinct aspects of the 
AAC/ANT interactome are likely to shed significant insight into how it supports complex 
IV biogenesis. 
1.5 Summary 
Mitochondrial carriers represent a vast array of transport proteins with essential 
biochemical and physiological functions. At the molecular level, the mechanistic basis for 
23 
 
their role(s) in the regulation of OXPHOS is still missing. Significant knowledge gaps exist 
in this area of research and discovery of new members and novel functions of existing 
members will give us a better understanding of their pathophysiological roles. Long term, 
such information may guide development of effective therapeutic strategies to correct or 
better manage disease resulting from their dysfunction. With recent advances in biomedical 
research such as the advent of gene editing technologies (e.g. CRISPR/Cas9), substantial 
and rapid progress in the field of solute carriers is anticipated. 
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SLC60 Glucose transporters 2  
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SLC64 Golgi Ca2+/H+ exchangers 1  
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aThe SLC subfamily, description and numbers of members in each subfamily are shown. 




Table 1.2: Current list of MCF membersa. 
SLC name Protein name Substrates 
SLC25A1 CIC (citrate carrier) 
citrate, isocitrate, malate, 
phosphoenolpyruvate  (PEP) 
SLC25A2 ORC2 (ornithine carrier 2) 
ornithine, citrulline, lysine, 
arginine, histidine 
SLC25A3 PHC (phosphate carrier) phosphate, Cu++ 
SLC25A4 




ANT2 (adenine nucleotide 
translocase-2) 
ADP, ATP 
SLC25A5P1 pseudogene  
SLC25A6 
ANT3 (adenine nucleotide 
translocase-3) 
ADP, ATP 
SLC25A6P1 pseudogene  
SLC25A7 UCP1 (uncoupling protein 1) H+ 
SLC25A8 UCP2 (uncoupling protein 2) H+ 
SLC25A9 UCP3 (uncoupling protein 3) H+ 
SLC25A10 DIC (dicarboxylate carrier) 
malate, phosphate, succinate, 
sulphate, thiosulphate 








AGC2 (aspartate / glutamate 
carrier 2) 
aspartate, glutamate 
SLC25A14 UCP5 (uncoupling protein 5) Orphan 
SLC25A15 ORC1 (ornithine carrier 1) 
ornithine, citrulline, lysine, 
arginine 
SLC25A15P1 pseudogene  
SLC25A16 






CoA, FAD, NAD+, AMP, ADP, 
PAP, dPCoA, FMN 








CAC (carnitine / 
acylcarnitine carrier) 
carnitine, acylcarnitine 
SLC25A20P1 pseudogene  
SLC25A21 ODC (oxoadipate carrier) oxoadipate, oxoglutarate 





mitochondrial carrier protein 
SCaMC-3 
ATP-Mg2+, ATP, ADP, AMP, Pi 
SLC25A24 
Calcium-binding 
mitochondrial carrier protein 
SCaMC-1 
ATP-Mg2+, ATP, ADP, AMP, Pi 
SLC25A25 
Calcium-binding 









SLC25A27 UCP4 (uncoupling protein 4) Orphan 
SLC25A28 Mitoferrin 2 (Mfrn2) Fe2+ 
SLC25A29 ORNT3 ornithine, acylcarnitine 
SLC25A30 
Kidney mitochondrial carrier 
protein 1 or UCP6 
(uncoupling protein 6) 
Orphan 
SLC25A31 
AAC4, ANT4 (adenine 
nucleotide carrier 4) 
ADP, ATP 
SLC25A32 MFT folate 
SLC25A33 





SLC25A34  Orphan 
SLC25A35  Orphan 
SLC25A36 
PNC2 (pyrimidine nucleotide 
carrier 2) 
pyrimidine nucleotides 
SLC25A37 Mitoferrin 1 (Mfrn1) Fe2+ 
SLC25A38  glycine ? 
SLC25A39  Orphan 
SLC25A40  Orphan 
SLC25A41 APC4 ATP-Mg / Pi 
SLC25A42 
Mitochondrial coenzyme A 
transporter 
CoA, ADP, ATP, adenosine 3',5'-
diphosphate, dPCoA 
SLC25A43  Orphan 
SLC25A44  Orphan 
SLC25A45  Orphan 
SLC25A46  Orphan 
SLC25A47  Orphan 
SLC25A48  Orphan 
SLC25A49 
Mitochondrial carrier 
homolog (MTCH) 1 
Orphan 
SLC25A50 MTCH2 Orphan 
SLC25A51 
Mitochondrial carrier triple 
repeat protein (MCART) 1 
Orphan 
SLC25A51P1 pseudogene  
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SLC25A51P2 pseudogene  
SLC25A51P3 pseudogene  
SLC25A52 MCART2 Orphan 
SLC25A53 MCART6 Orphan 
 aThe SLC and protein names, and transported substrate(s) of each MCF member. Further 




Table 1.3: Summary of known MCF-involved diseases clustered by systemic 
presentation. 
System Clinical presentation/disease and MCF member associated 
Hematopoietic Sideroblastic anemia: SLC25A38 OMIM 205950 (Guernsey et 
al., 2009; Harigae & Furuyama, 2010; Horvathova et al., 2010) 
Metabolic Lactic acidosis: SLC25A4 (Bakker et al., 1993; L. Palmieri et 
al., 2005; Thompson et al., 2016); SLC25A26 OMIM 616794 
(Kishita et al., 2015) 
Citrullinemia: SLC25A13 OMIM 603471 and 605814  
(Fiermonte et al., 2008; Kobayashi et al., 1999; Ohura et al., 
2001; Tazawa et al., 2001; Yasuda et al., 2000) 
Hydroxyglutaric aciduria: SLC25A1 OMIM 615182 
(Edvardson et al., 2013; Muntau et al., 2000; Nota et al., 2013) 
 Hyperornithinemia-Hyperammonemia-Homocitrullinuria 
(HHH) Syndrome: SLC25A15 OMIM 603861 (Camacho et al., 
1999; Debray et al., 2008; Miyamoto et al., 2001; Salvi et al., 
2001; Tessa et al., 2009; Tsujino et al., 2000) 
Hypoglycemia, Hyperammonemia: SLC25A20 OMIM 
212138  (Iacobazzi et al., 2004; Pande et al., 1993; Stanley et al., 
1992) 




Exercise intolerance: SLC25A32 OMIM 616839 (Hellebrekers 
et al., 2017; Schiff et al., 2016) 
Cardiovascular Hypertrophic cardiomyopathy: SLC25A4 OMIM 615418 
(Echaniz-Laguna et al., 2012; Körver-Keularts et al., 2015; L. 
Palmieri et al., 2005), OMIM 617184 (Thompson et al., 2016); 
SLC25A3 OMIM  610773 (Bhoj et al., 2015; Mayr et al., 2007); 
SLC25A20 OMIM 212138  (Dong et al., 2015; Dong et al., 2011; 
Huizing et al., 1998; Iacobazzi et al., 2004; Nakase et al., 2007; 
Pande et al., 1993; Stanley et al., 1992; Van De Parre et al., 2008) 
Pulmonary Respiratory insufficiency: SLC25A26 OMIM 616794 (Kishita 
et al., 2015) 
Musculoskeletal Myopathy: SLC25A4 OMIM 615418 (Bakker et al., 1993; 
Echaniz-Laguna et al., 2012; Körver-Keularts et al., 2015; L. 
Palmieri et al., 2005), OMIM 617184 (Thompson et al., 2016); 
SLC25A3 OMIM  610773 (Mayr et al., 2007); SLC25A26 
OMIM 616794 (Kishita et al., 2015); SLC25A32 (Hellebrekers 
et al., 2017) 
Progressive External Ophthalmoplegia: SLC25A4 OMIM 
609283 (Kaukonen et al., 2000; Lamantea et al., 2002; Napoli et 
al., 2001)  
Neurological Epileptic encephalopathy: SLC25A12 OMIM 612949 (Falk et 
al., 2014; Wibom et al., 2009); SLC25A22 OMIM 609304 
(Molinari et al., 2009; Molinari et al., 2005; Poduri et al., 2013) 
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Microcephaly: SLC25A19 OMIM 607196 (Hellebrekers et al., 
2017; Rosenberg et al., 2002) 
Neuropathy: Progressive polyneuropathy - SLC25A19 OMIM 
613710 (Spiegel et al., 2009); Charcot-Marie-Tooth Disease – 
SLC25A46 OMIM 616505 (Abrams et al., 2015; Charlesworth 
et al., 2016; Janer et al., 2016; Wan et al., 2016) 
Ataxia, Myoclonus, dysarthria: SLC25A32 (Hellebrekers et 
al., 2017) 
Gastrointestinal Cholestatic jaundice: SLC25A13 OMIM 605814  (Ohura et al., 
2001; Tamamori et al., 2002; Tazawa et al., 2001) 
Hepatic Steatosis: SLC25A13 OMIM 603471 (Komatsu et al., 
2008) 
General Progeroid syndrome: SLC25A24 OMIM 612289 (Ehmke et al., 







Figure 1.1: Schematic of the MCF tripartite structure. The structure of members of the 
mitochondrial carrier family can be seen as three similar parts/domains with approximately 
100 amino acids each. In each part, there are two alpha-helix transmembrane segments 
connected by a long matrix localized hydrophilic loop. The NH2- and COOH- terminal are 




Figure 1.2: Overview of the Heme biosynthetic pathway. Three known MCF member are 
involved in the first and last step of heme biosynthesis. The first step of the pathway is the 
reaction of the condensation of glycine and succinyl-CoA to form ALA by ALA synthase. 
Glycine is transported across the inner mitochondrial membrane by SLC25A38. The last 
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step which generate heme from protoporphyrin IX by incorporation of ferrous ion is 
catalyzed by ferrochetalase. Iron crosses the inner mitochondrial membrane via the 
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The ADP/ATP carrier regulates mitochondrial translation  
 
Sections of this chapter are derived from: 
Oluwaseun B. Ogunbona, Matthew G Baile, Steven M. Claypool (2018). Cardiomyopathy-
associated mutation in the ADP/ATP carrier reveals translation-dependent regulation of 





How the absence of the major mitochondrial ADP/ATP carrier in yeast, Aac2p, results in 
a specific defect in cytochrome c oxidase (COX; complex IV) activity is a long-standing 
mystery. Aac2p physically associates with respiratory supercomplexes, which include 
complex IV, raising the possibility that its activity is dependent on its association with 
Aac2p. Here, we have leveraged a transport-dead pathogenic AAC2 point mutant to 
determine the basis for the reduced COX activity in the absence of Aac2p. The steady state 
levels of complex IV subunits encoded by the mitochondrial genome are significantly 
reduced in the absence of Aac2p function, whether its association with respiratory 
supercomplexes is preserved or not. This diminution in COX amounts is not caused by a 
reduction in the mitochondrial genome copy number or the steady state level of its 
transcripts and does not reflect a defect in complex IV assembly. Instead, the absence of 
Aac2p activity, genetically or pharmacologically, results in an aberrant pattern of 
mitochondrial translation. Interestingly, compared to the complete absence of Aac2p, the 
complex IV-related defects are greater in mitochondria expressing the transport-inactive 
Aac2p mutant. Our results highlight a critical role for Aac2p transport in mitochondrial 








Life is energetically costly. The major energy currency in cells comes in the form 
of ATP, most of which is produced in the mitochondrion by the combined activities of a 
series of inner membrane proton pumps (complexes I, III, IV, and V), the last of which 
physiologically works in reverse. This process, which is known as oxidative 
phosphorylation (OXPHOS), additionally requires two mitochondrial carrier proteins, the 
phosphate carrier (Pic) and the ADP/ATP carrier (Aac). A symporter, Pic couples the 
downhill flow of protons across the inner membrane to the transport of phosphate into the 
mitochondrial matrix (Wohlrab & Flowers, 1982). Aac mediates the exchange of ADP into 
for ATP out of the matrix, a process that is driven by the electrical gradient across the inner 
membrane that is established by the electron transport chain (Klingenberg, 2008). Thus, 
Pic and Aac utilize the chemical and electrical components of the electrochemical gradient, 
respectively, to provide the substrates, Pi and ADP, needed by complex V to make ATP. 
By reducing the electrochemical gradient, Pic and Aac make it easier for complexes I, III 
and IV to pump protons. Further, their transport activity is a core feature of respiratory 
control, the classic mode of OXPHOS regulation. In the absence of ADP (or Pi), complex 
V is unable to couple the downhill flow of protons to the synthesis of ATP. This increases 
the electrochemical gradient to a level that effectively shuts off further proton pumping. 
Upon the addition of ADP and its transport into the matrix by Aac, complex V function 
resumes, decreasing the electrochemical gradient and thus increasing the activity of the 




In humans, ADP/ATP carriers are called adenine nucleotide translocases (ANT). 
There are three Aac isoforms in yeast and four ANT isoforms in human. All of these 
isoforms are encoded by distinct genes. The four human ANT isoforms display a tissue-
specific and yet partially overlapping expression pattern. ANT1 is the predominant isoform 
in the heart and skeletal muscle (Stepien, Torroni, Chung, Hodge, & Wallace, 1992), ANT2 
is highly-expressed in regenerative tissues such as kidney and liver, ANT3 is ubiquitously 
expressed at low baseline levels, and ANT4 is contained in testis (Doerner et al., 1997; 
Dolce, Scarcia, Iacopetta, & Palmieri, 2005; Dupont & Stepien, 2011; Stepien et al., 1992). 
Of the three yeast Aac isoforms, only Aac2p is required for OXPHOS (Lawson, Gawaz, 
Klingenberg, & Douglas, 1990). Aac1p and Aac3p are minor isoforms whose expression 
is repressed in hypoxic (Gavurníková, Sabova, Kissová, Haviernik, & Kolarov, 1996) or 
induced in anaerobic (Sabová, Zeman, Supek, & Kolarov, 1993) conditions, respectively.    
ANT1 deficiency is implicated in various pathological states, such as hypertrophic 
cardiomyopathy, mitochondrial myopathy, lactic acidosis, progressive external 
ophthalmoplegia, facioscapulohumeral muscular dystrophy, and Sengers syndrome 
(Echaniz-Laguna et al., 2012; Fontanesi et al., 2004; Graham et al., 1997; Jordens et al., 
2002; Kaukonen et al., 2000; Komaki et al., 2002; Palmieri et al., 2005; Sharer, 2005; 
Thompson et al., 2016). Mutations in ANT2 have been associated with non-syndromic 
intellectual disability (Vandewalle et al., 2013) and cardiac noncompaction (Kokoszka et 
al., 2016) and its dysregulation associated with a Warburg metabolic phenotype 
(Maldonado et al., 2016).  Presumably, the impacted tissues reflect the expression pattern 
of ANT isoforms. However, whether these pathologies all result simply from impaired 
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OXPHOS function or additionally include isoform specific activities unrelated to 
OXPHOS remains an open question. 
It was demonstrated by us and others that Aac2p physically associates with the 
respiratory supercomplex (RSC), higher order assemblies of individual respiratory 
complexes (Acín-Pérez, Fernández-Silva, Peleato, Pérez-Martos, & Enriquez, 2008; Gu et 
al., 2016; Letts, Fiedorczuk, & Sazanov, 2016; Moreno-Lastres et al., 2012; Schägger & 
Pfeiffer, 2000; Wu, Gu, Guo, Huang, & Yang, 2016), as well as other mitochondrial 
carriers, but only in the context of mitochondrial membranes that contain the unique 
phospholipid cardiolipin (Claypool, Oktay, Boontheung, Loo, & Koehler, 2008; Dienhart 
& Stuart, 2008). Importantly, we have recently established that the interaction between the 
ADP/ATP carrier and the respiratory supercomplexes is evolutionarily conserved (Lu et 
al., 2017), implying that this association is functionally important. However, the functional 
significance of the Aac2p interaction with respiratory supercomplexes has not been 
provided. 
The absence of Aac2p in yeast not only prevents OXPHOS but additionally results 
in a specific diminution in complex IV activity (Claypool et al., 2008; Dienhart & Stuart, 
2008; Fontanesi et al., 2004; Heidkämper, Müller, Nelson, & Klingenberg, 1996; Müller, 
Basset, Nelson, & Klingenberg, 1996). The mechanistic basis for the reduced complex IV 
function when Aac2p is missing has not been established. In the present study, we have 
modeled a transport-dead pathogenic ANT1 point mutant discovered in a patient with 
hypertrophic cardiomyopathy and mild myopathy in AAC2 to determine whether the 
reduction in complex IV activity when Aac2p is missing reflects the absence of the 
interaction between Aac2p and components of the electron transport chain and/or the lack 
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of nucleotide transport (i.e. Aac2p function). Importantly, the functionally inactive A137D 
allele of AAC2 (aac2A137D) is expressed normally and still interacts with components of the 
yeast respiratory supercomplex. In the absence of Aac2p function, the expression levels of 
complex IV subunits that are encoded by the mitochondrial genome (and which form the 
catalytic core of the complex IV holoenzyme) are specifically reduced. This reduction in 
the levels of complex IV subunits is not caused by a decrease in mitochondrial genome 
copy number or levels of mitochondrial DNA transcripts, nor does it result from any 
alteration in complex IV assembly. Instead, mitochondrial translation is altered in the 
absence of Aac2p activity. Interestingly, compared to the complete absence of Aac2p, the 
complex IV-related defects are greater in mitochondria expressing the transport-inactive 
Aac2A137D. Collectively, our results highlight the importance of Aac2p function for the 
normal translation of the mitochondrial encoded complex IV subunits and further 






Aac2A137D is non-functional but assembles like wild type Aac2p  
In yeast, complex IV function is specifically impaired in the absence of Aac2p. 
Even though this was first documented over two decades ago (Heidkämper et al., 1996; 
Müller et al., 1996) and subsequently confirmed by multiple groups (Claypool et al., 2008; 
Dienhart & Stuart, 2008; Fontanesi et al., 2004), the underlying mechanism has never been 
provided. In principle, Aac2p could support full complex IV activity by either mediating 
the flux of ADP and ATP across the inner membrane (Heidkämper et al., 1996) and/or by 
virtue of its physical association with the respiratory supercomplexes (Claypool et al., 
2008; Dienhart & Stuart, 2008). To distinguish between these possibilities, we decided to 
leverage a pathogenic allele of ANT1, ANT1A123D, identified in a patient suffering from 
exercise intolerance, lactic acidosis, hypertrophic cardiomyopathy, and mild myopathy 
(Palmieri et al., 2005). Interestingly, although the mutant protein is expressed at normal 
levels, it fails to mediate uptake of ATP upon reconstitution of muscle-derived 
mitochondrial extracts into liposomes.  Moreover, when modeled in the yeast ortholog, 
Aac2A137D is expressed at wild type levels, lacks ADP/ATP exchange in reconstituted 
liposomes, and fails to support respiratory growth (Palmieri et al., 2005). However, the 
quaternary assembly of Aac2A137D has not been documented. We reasoned that if Aac2A137D 
retains its ability to interact with other proteins, including the RSCs, it would provide an 
ideal tool to determine exactly how Aac2p controls complex IV activity.  
 Using CRISPR-Cas9, genomic mutations were introduced in AAC2 that either 
resulted in a premature stop codon (aac2Δ) or the expression of the aac2A137D mutant allele 
(Figure 2.1A). These genetic modifications were introduced in the presence or absence of 
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Aac1p and Aac3p, to evaluate if the minor Aac isoforms could potentially compensate for 
the absence of Aac2p function. As anticipated (Palmieri et al., 2005), Aac2A137D was 
expressed like wild type Aac2p but unable to support growth on respiratory media (Figure 
2.1A and B). Next, Aac2A137D assembly was compared to wild type Aac2p by blue native 
(BN)-PAGE (Figure 2.1C). Indeed, Aac2A137D engaged in a normal range of complexes 
that were not influenced by the presence or absence of the minor Aac isoforms. 
Importantly, the Aac2A137D -containing complexes included high molecular weight 
associations with respiratory supercomplexes that consist of a complex III dimer associated 
with 1-2 copies of complex IV. In the absence of Aac2p function (aac2Δ and aac2A137D), 
the relative abundance of the small supercomplex (III2IV) was increased and free complex 
III dimers were readily detected (Figure 2.1D and E). These alterations suggest that the 
steady state level of complex IV is perhaps limiting when Aac2p is non-functional. To 
directly determine the ability of Aac2A137D to associate with respiratory supercomplexes, 
we established yeast strains in which a FLAG tag was genomically appended to the C-
terminus of either the complex IV subunit, Cox8p, or the complex III subunit, Qcr10p 
(Figure 2.9). Indeed, Aac2A137D was co-immunoprecipitated with either Cox8-3XFLAG 
(Figure 2.1F) or Qcr10-3XFLAG (Figure 2.9A). Finally, the levels of ADP and ATP in 
mitochondria were determined as a proxy of Aac2A137D function.  In the absence of Aac2p 
activity, the level of mitochondrial ATP was significantly reduced (Figure 2.1H) which 
resulted in an elevated ADP:ATP ratio (Figure 2.1I). Interestingly, ADP levels were only 
significantly decreased for aac2A137D and not aac2∆ (Figure 2.1G). Combined, these results 
indicate that Aac2A137D is an assembly-competent, transport-inactive molecular tool that 
can be used to probe the molecular basis for the reduced complex IV activity that occurs 
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when Aac2p is not expressed (Claypool et al., 2008; Dienhart & Stuart, 2008; Fontanesi et 
al., 2004; Heidkämper et al., 1996; Müller et al., 1996). 
Impaired complex IV activity and expression in the absence of Aac2p function 
With the goal of determining if complex IV activity is dependent on its physical 
association with Aac2p, we next compared complex IV function in mitochondria that 
express either transport-active Aac2p, the transport-inactive Aac2A137D, or that lack Aac2p 
expression completely. To determine complex IV activity in isolation, the rate of 
cytochrome c oxidation was tracked spectrophotometrically using mitochondria 
solubilized with n-dodecyl β-D-maltoside (DDM), a detergent that separates respiratory 
supercomplexes into its individual components (Schägger, 2001) (Figure 2.2A). To assess 
complex IV function in intact, non-detergent solubilized mitochondria, the ascorbate-
TMPD (N,N,N′,N′-tetramethyl-p-phenylenediamine) dependent basal and uncoupled 
respiration rates, the only measurements that are relevant in the absence of Aac2p function, 
were determined (Figure 2.2B and C). Regardless of the method, complex IV (Figure 2.2A-
C), but not complex III (Figure 2.2D), activity was significantly reduced in mitochondria 
that lack Aac2p function. Interestingly, the level of complex IV activity supported by the 
transport-inactive Aac2A137D was even lower than detected in aac2∆ (Figure 2.2A-C). 
Thus, the reduced complex IV activity in aac2∆ extracts stems from the absence of Aac2p–
mediated ADP/ATP exchange and not from the lack of the Aac2p–respiratory 
supercomplex interaction. 
 Next, the relative abundance of various complex IV subunits was determined in 
isolated mitochondria (Figure 2.2E). In yeast, complex IV has eleven total subunits, three 
of which–Cox1p, Cox2p, and Cox3p–are encoded by the mitochondrial genome. The 
86 
 
steady state levels of all three mitochondrial DNA (mtDNA)-encoded complex IV subunits 
was significantly reduced in the absence of Aac2p function (Figure 2.2E and quantified in 
Figure 2.2F and 2.10). This impacted the abundance of other complex IV subunits encoded 
by the nuclear genome such as Cox5Ap and Cox4p. mtDNA encoded subunits of complex 
V (Atp6p and Atp9p) were also reduced when Aac2p activity is missing, although not as 
drastically as the complex IV subunits. The steady state amounts of nuclear-encoded 
subunits of complex III (except for Qcr7p which was affected in the aac2A137D mutant but 
not in aac2∆) and complex V, as well as markers of the outer membrane, inner membrane, 
and matrix compartments (Tom70p, Pic1p, and Kgd1p, respectively), were not altered 
when Aac2p was absent or non-functional. The relative decrease in steady state abundance 
of mtDNA-encoded complex IV subunits was roughly proportional to the reduction in 
complex IV activity observed in mitochondria when Aac2p was not expressed at all (25-
61% decrease in expression vs. 43-59% decrease in activity). Similarly, complex IV 
activity was compromised proportionately to its expression, although to a greater extent in 
the transport-inactive aac2A137D mutant (62-89% decrease in expression vs 59-76% 
decrease in activity). This suggests that it is more detrimental to express a non-functional 
version of Aac2p than to not express it at all. From these results, we conclude that Aac2p 
activity controls complex IV functionality by specifically affecting the levels of mtDNA-
encoded subunits of cytochrome c oxidase. 
Mitochondrial translation is altered in the absence of Aac2p function 
The steady state level of a protein is dictated by how robustly it is produced 
combined with how stable it is once it is made. Therefore, to determine the basis for the 
reduced steady state levels of mtDNA-encoded complex IV subunits, we started at the 
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genetic source of these subunits and determined mitochondrial DNA copy number relative 
to the nuclear genome by qPCR. Consistent with the fact that aac2∆ yeast are so-called 
petite-negative (that is, yeast lacking Aac2p are unable to survive in the absence of the 
mtDNA) (Kovác, Lachowicz, & Slonimski, 1967), mtDNA copy number was not 
significantly altered in strains lacking Aac2p activity compared to strains that have Aac2p 
activity (Figure 2.3A). We next reasoned that a specific reduction in the levels of complex 
IV subunits encoded by mtDNA could stem from a defect in their transcription. However, 
the relative abundance of transcripts that encode for subunits of complex IV (COX1-3) or 
complex V (ATP6 and ATP9) were not impacted by the presence or absence of Aac2p 
function (Figure 2.3B-F).  
These results suggest that Aac2p function regulates the steady state accumulation 
of mtDNA-encoded complex IV subunits through a post-transcriptional mechanism(s). As 
such, the translation of mtDNA-encoded proteins was determined by tracking the 
incorporation of 35S-methionine/cysteine in yeast cultured in the presence of 
cycloheximide to inhibit cytosolic translation (Figure 2.4A and 2.11A). In the absence of 
Aac2p activity, translation of Cox1p and Cox2p was reduced while curiously, translation 
of Atp6p and Atp9p was increased relative to Aac2p-expressing yeast (Figure 2.4A and 
2.11A). This latter change resulted in a significantly reduced ratio of newly translated 
Cox3p to Atp6p in yeast devoid of Aac2p activity (Figure 2.4B). Translation of Var1p was 
similar amongst the different yeast strains (Figure 2.11B) and while the overall 
incorporation of 35S-Met/Cys was greatest when Aac2p was not expressed, this was not 
statistically significant (Figure 2.11C). Next, pulse-chase experiments were performed to 
determine if the absence of Aac2p function altered the stability of newly translated 
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mtDNA-encoded polypeptides (Figure 2.4C). In the absence, but not the presence, of the 
minor Aac isoforms, the stability of Cox1p and Cox2p was compromised in the context of 
the transport-inactive Aac2A137D mutant (Figure 2.4 E and F). However, since the steady 
state levels of Cox1p and Cox2p were similarly decreased in Aac2A137D mitochondria with 
or without the minor Aac isoforms (Figure 2.3), it is unlikely that the stability of newly 
translated Cox1p and Cox2p significantly contributes to their reduced steady state levels. 
Instead, their translation appears to correlate more strongly with their final steady state 
abundance. In contrast, the stability of freshly translated Cox3p was decreased in Aac2A137D 
mitochondria regardless of the presence of the minor Aac isoforms (Figure 2.4G). 
Surprisingly, the stability of newly translated Atp6p was increased when Aac2p function 
was lacking (Figure 2.4H). An increased translation of Atp6p (Figure 2.4A) combined with 
an enhanced stability of newly made polypeptide (Figure 2.4H) would be expected to result 
in increased steady state Atp6p levels, something that was not observed (Figure 2.2). 
Finally, in the presence, but not the absence, of the minor Aac isoforms, the turnover of 
Cob1p and Var1p was modestly but significantly increased when Aac2p is missing (aac2∆) 
(Figure 2.4 I and J).  
Overall, our results indicate that when Aac2p function is absent, mitochondrial 
translation is dysregulated such that the production of the complex IV subunits Cox1p and 
Cox2p, and the complex V subunits Atp6p and Atp9p, is decreased and increased, 
respectively. Further, our data suggest that the relatively lower steady state levels of 
mtDNA-encoded complex IV subunits in aac2A137D versus aac2Δ mitochondria (Figure 
2.3) may stem in part from a reduced stability of newly translated Cox3p in the former 
(Figure 2.4G).  
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Import and assembly of nuclear encoded subunits of cytochrome c oxidase is not 
disturbed in the absence of Aac2p function 
 The assembly of complexes III, IV, and V in yeast involves the coordinated 
incorporation of proteins from two genomes, and for the two respiratory complexes, the 
complement of prosthetic groups that endow them with the ability to move electrons. 
Current evidence suggests that the three mtDNA-encoded COX subunits form three 
independent modules of distinct composition (McStay, Su, Thomas, Xu, & Tzagoloff, 
2013; McStay, Su, & Tzagoloff, 2013; Su, McStay, & Tzagoloff, 2014). The assembly of 
these modules is closely monitored and tightly regulated. For example, Mss51p is a Cox1p 
translational activator that additionally functions as a chaperone that physically stabilizes 
nascent Cox1p (Barrientos, Korr, & Tzagoloff, 2002; Mick et al., 2010; Perez-Martinez, 
Broadley, & Fox, 2003; Siep, van Oosterum, Neufeglise, van der Spek, & Grivell, 2000). 
When functioning as a chaperone, Mss51p is unable to act as a Cox1p translational 
enhancer. As such, Cox1p synthesis is directly linked to the fidelity of its assembly. The 
complex IV holoenzyme is generated by the association of the three fully assembled 
modules and any remaining subunits. 
Since a defect in complex IV assembly can negatively feedback to reduce 
mitochondrial translation of complex IV subunits (Barrientos, Zambrano, & Tzagoloff, 
2004; Perez-Martinez et al., 2003; Soto, Fontanesi, Liu, & Barrientos, 2012; Towpik, 
2005), we reasoned that Aac2p function may be specifically important for the assembly of 
complex IV. To test this model, we compared the incorporation of newly imported subunits 
into complex IV and complex IV-containing supercomplexes in mitochondria that contain 
or lack Aac2p activity (Brandner et al., 2005). To monitor multiple stages of complex IV 
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assembly, we followed the import and assembly of radiolabeled Cox5Ap and Cox13p, 
which are integrated into the Cox1p (McStay, Su, Thomas, et al., 2013; McStay, Su, & 
Tzagoloff, 2013) and Cox3p (Su et al., 2014) modules, respectively (Figure 2.5A). Both 
precursors were imported into isolated mitochondria in a time and membrane-potential 
dependent manner regardless of the presence or absence of Aac2p function (Figure 2.5B 
and C). Further, their incorporation into complex IV and complex IV-containing 
respiratory supercomplexes was not impacted by the absence of Aac2p transport (Figure 
2.5D and E). Interestingly, the incorporation of radiolabeled Cox5Ap into complex IV-
containing complexes was increased in aac2∆ mitochondria compared to mitochondria 
expressing either transport-active or transport-inactive Aac2p. While the basis for this 
observation is presently unclear, it is unlikely to reflect reduced steady state levels of 
Cox5Ap which were normal in aac2∆ mitochondria (Figure 2.2E). 
Altered mitochondrial translation in the absence of Aac2p function is reversible 
Mss51p, a specific translational activator of COX1 mRNA, is involved in complex 
IV biogenesis by regulating the synthesis of Cox1p (Siep et al., 2000). When Mss51p is 
trapped in a complex consisting of unassembled Cox1p and other proteins it is prevented 
from enhancing Cox1p translation (Barrientos et al., 2004; Fontanesi, Clemente, & 
Barrientos, 2011; Perez-Martinez et al., 2003; Perez-Martinez, Butler, Shingu-Vazquez, & 
Fox, 2009). Unlike its translational target and subsequent client Cox1p, Mss51p 
accumulated normally in the absence of Aac2p activity (Figure 2.6A). Next, the ability of 
overexpressed Mss51p to rescue mitochondrial protein synthesis in the absence of Aac2p 
function was determined (Figure 2.6B). However, mitochondrial translation was not 
altered when Mss51p was overexpressed regardless of the presence or absence of Aac2p 
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function (Figure 2.6B and 2.12A). These results indicate that the availability of Mss51p to 
serve as a COX1 translational activator is not limiting in the absence of Aac2p activity. As 
such, the reduced translation of complex IV subunits that occurs when Aac2p function is 
missing does not derive from any changes in Mss51p expression and function. 
 Aim23p or mIF3p (mitochondrial translation initiation factor 3), the 
Saccharomyces cerevisiae homolog of the bacterial translation initiation factor 3 (IF3), has 
conserved and overlapping functions with human mIF3p (Atkinson et al., 2012; Kuzmenko 
et al., 2014). Translation initiation factors act at a critical point between the first (translation 
initiation) and last (ribosomal recycling) steps of the translational cycle, ensuring correct 
tRNA and mRNA selection; however, unlike translational activators, translation initiation 
factors do not directly interact with mRNAs (Kuzmenko et al., 2014). Aim23p disruption 
results in disturbed mitochondrial translation (Kuzmenko et al., 2016), similar to what we 
have observed in the absence of Aac2p function (Figure 2.3). As such, we investigated 
whether Aim23p is involved in the abnormal mitochondrial translation detected in absence 
of Aac2p function. However, not only was its steady state abundance normal in the absence 
of Aac2p activity (Figure 2.6C), overexpression of Aim23p failed to improve the Aac2p-
related mitochondrial translation defect (Figure 2.6D and 2.12B). Thus, it would appear 
that the altered mitochondrial translation in the absence of Aim23p or Aac2p are 
mechanistically unrelated. 
 As a control, we determined the ability of overexpressed WT Aac2p to rescue the 
translational impairment that occurs when Aac2p function is absent. As expected, re-
introduction of Aac2p increased the translation of mitochondrial encoded subunits of 
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complex IV (Figure 2.6, B and D) and restored their steady state amounts (Figure 2.12C) 
in both aac2Δ and aac2A137D yeast. 
Acute Aac2p inhibition alters mitochondrial translation  
To gain further insight into how Aac2p function promotes normal mitochondrial 
translation, we asked whether acute inhibition of Aac2p activity using the membrane 
permeable Aac2p inhibitor, bongkrekic acid (BKA), could prevent the rescued translation 
of complex IV subunits provided by overexpressed WT Aac2p. Indeed, the increased 
translation of complex IV subunits was prevented by the inclusion of BKA in the context 
of either aac2A137D rescued with overexpressed Aac2p (Figure 2.7 A and B) or the WT 
strain with endogenous or overexpressed Aac2p (Figure 2.7 C and D). Since this effect 
occurred after only 10 min of Aac2p inhibition, this suggests that the altered mitochondrial 
translation detected upon genetic inactivation of Aac2p function does not stem from 
compensatory processes and instead reflects a direct functional link between Aac2p 
mediated transport and normal mitochondrial translation.  
Acute Aac2p inhibition reduces the stability of nascent Cox3p 
 The stability of nascent Cox3p was specifically decreased in Aac2A137D 
mitochondria (Figure 2.4G). Since inhibition of WT Aac2p with BKA results in a protein 
that is expressed but non-functional, similar to Aac2A137D, we determined if acute Aac2p 
inhibition also increases the turnover of newly translated Cox3p. We initially performed a 
series of experiments using aac2A137D rescued with overexpressed Aac2p, with empty 
vector transformed WT and aac2A137D yeast serving as controls (Figure 2.13). Surprisingly, 
the stability of Cox3p was unaffected by BKA in any of the tested strains (Figure 2.13E). 
However, the turnover of Cox3p was notably different in untransformed (Figure 2.4G) 
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versus empty vector (EV)-transformed WT yeast (Figure 2.13E). To determine if these 
discrepant results stem from the different media employed (e.g. rich media versus minimal 
auxotrophic selection media), we compared WT and aac2A137D strains with/without empty 
vector, grown in either rich or synthetic media lacking leucine. Indeed, total translation of 
mtDNA was decreased in the EV-transformed strains compared to their untransformed 
relatives (Figure 2.14A). Further, Cox3p stability notably differed in the untransformed 
versus the EV-transformed WT strain (Figure 2.14E); Cox3p was notably more stable in 
the untransformed WT strain. These results indicate that both mtDNA translation and the 
stability of its newly produced polypeptides is sensitive to either the growth conditions 
used and/or the presence of an episomal plasmid. 
 Therefore, we asked if acute Aac2p inhibition with BKA increases the turnover of 
nascent Cox3p in untransformed WT and aac2A137D yeast (Figure 2.8). Indeed, BKA 
treatment enhanced the turnover of Cox3p in the WT strain expressing endogenous Aac2p, 
although its rate of degradation was not as fast as in aac2A137D yeast (Figure 2.8E). As 
expected, BKA treatment did not further increase the turnover of Cox3p in aac2A137D yeast.  
The stability of other newly translated proteins was unaffected by acute Aac2p inhibition 
except for Atp6p, whose turnover was modestly increased in BKA-treated WT yeast 
(Figure 2.8 C-H).  These results demonstrate that the stability of nascent Cox3p is 






Consistent with its role as the main conduit for ADP and ATP across the inner 
membrane, yeast lacking Aac2p activity, due to gene deletion or destabilizing mutations 
(Heidkämper et al., 1996; Müller et al., 1996; Müller, Heidkämper, Nelson, & Klingenberg, 
1997; Nelson, Lawson, Klingenberg, & Douglas, 1993), are unable to grow on respiratory 
media due to a complete block in OXPHOS (Lawson et al., 1990). What is perhaps 
surprising is that the absence of Aac2p specifically impairs the function of complex IV, but 
not complex III (Dienhart & Stuart, 2008) (Figure 2.2 A-D). Potential insight into the 
underlying mechanism, which has remained unresolved for over twenty years, was 
provided by the demonstration that Aac2p physically associates with respiratory 
supercomplexes consisting of complex III and IV (Claypool et al., 2008; Dienhart & Stuart, 
2008). The goal of the present study was to determine if complex IV activity is dependent 
on its physical association with Aac2p or instead Aac2p-mediated ADP/ATP transport. 
Utilizing a transport-null Aac2p mutant to distinguish between these possibilities, we have 
established that robust complex IV function requires Aac2p-based transport and not its 
physical association. In fact, if anything, the transport-null allele, which retained its ability 
to associate with complex IV-containing supercomplexes, resulted in more severe 
phenotypes than when Aac2p was completely missing.  
How does the absence of Aac2p activity specifically impair complex IV function? 
Initial insight into the underlying mechanism was that the steady state amount of all three 
complex IV subunits encoded by the mitochondrial genome was significantly reduced 
when Aac2p function is missing. As expected, the levels of mtDNA in strains lacking 
Aac2p function was normal (Kovác et al., 1967). In yeast, mitochondrial transcription can 
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be regulated by nucleotide levels through the ability of the mitochondrial RNA polymerase, 
Rpo41p, to sense fluctuations in ATP levels (Amiott & Jaehning, 2006; Asin-Cayuela & 
Gustafsson, 2007). However, even though the absence of Aac2p activity resulted in altered 
mitochondrial ADP and ATP levels and a disturbed ADP:ATP ratio, mtDNA transcript 
levels were not affected, consistent with a prior study (Kucejova, Li, Wang, Giannattasio, 
& Chen, 2008). While the abundance of mtDNA transcripts was normal in the absence of 
Aac2p function, their subsequent translation was not. Whereas the synthesis of Cox1-3p 
was reduced, the translation of mtDNA encoded complex V subunits was increased. 
Curiously, while the steady state amount of Cox1-3p mirrored their translation, this was 
not the case for the complex V subunits. Overall, these finding indicate that while 
mitochondrial translation is not globally impaired by the absence of Aac2p function, it is 
significantly dysregulated.  
One potential explanation for the reduced translation of COX subunits when Aac2p 
activity is missing is that the assembly of complex IV, which is known to tightly regulate 
translation of subunits through feedback mechanisms, is impaired. For example, a 15-base 
pair deletion in human Cox3p which decreases its stability additionally reduces the 
synthesis and stability of Cox1p and Cox2p and impairs the assembly of complex IV 
(Hoffbuhr et al., 2000). In yeast, Cox1p synthesis is significantly decreased by mutations 
in COX2 or the COX3 translational activators, PET54 and PET122, in a way that appears 
to be mediated by the assembly status of  complex IV (Shingú-Vázquez et al., 2010). 
However, not only was complex IV assembly normal at steady state, the kinetics of its 
assembly was the same in the presence or absence of Aac2p function. An assembly defect 
could lead to accumulation of unassembled polypeptides and/or assembly intermediates 
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which could become toxic if not resolved. However, deletion of Oma1p, which is involved 
in the degradation of unassembled subunits of complex IV in certain situations (Bestwick, 
Khalimonchuk, Pierrel, & Winge, 2010; Khalimonchuk, Jeong, Watts, Ferris, & Winge, 
2012), did not rescue the steady state level of complex IV subunits when Aac2p function 
is missing (Figure 2.15). In humans, truncating mutations in COX1 have been shown to 
destabilize other complex IV subunits via a mechanism that requires the activity of the m-
AAA protease even though the truncated Cox1p polypeptide is still able to assemble with 
other complex IV subunits as well as other respiratory complexes (Hornig-Do et al., 2012). 
Unfortunately, potential roles for the two mitochondrial AAA proteases Yme1p and 
Yta10p/Yta12p have not been determined since loss of Aac2p function is synthetically 
lethal with yme1∆ (Wang, Salinas, Zuo, Kucejova, & Chen, 2008) and complex IV subunits 
do not accumulate in the absence of Yta10p/Yta12p (Arlt et al., 1998). These results 
suggest that the low steady state amounts of mtDNA-encoded complex IV subunits in the 
absence of Aac2p activity stems from their reduced translation and not to a complex IV 
assembly defect.  
Interestingly, the complex IV-related perturbations were greater in the context of 
the transport-null Aac2p mutant than when Aac2p was entirely gone. This was not due to 
compensation by the minor Aac isoforms since the same trend was observed in the presence 
and absence of Aac1p and Aac3p. Interestingly, the stability of newly translated Cox3p 
was compromised in yeast expressing the inactive Aac2p mutant but not in yeast lacking 
Aac2p altogether. Similarly, inhibition of Aac2p with BKA, also specifically increased the 
turnover of Cox3p in WT yeast. We speculate that the reduced stability of nascent Cox3p 
may contribute to the more drastic decrease in steady state levels of mtDNA-encoded 
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complex IV subunits in aac2A137D versus aac2Δ mitochondria. These results raise the 
possibility that a high ATP-demanding process exists that is required for the stability of 
newly made but unassembled Cox3p. Moreover, the increased turnover of nascent Cox3p 
only occurs when Aac2p is present but non-functional suggesting that Aac2p facilitates the 
degradation of Cox3p via an activity that is distinct from its role in ADP/ATP exchange. 
Another potential explanation for the more severe complex IV phenotype of the transport-
null Aac2p mutant was based on the identification of Mss51p as a potential Aac2p binding 
partner (Claypool et al., 2008). If the ability of Mss51p to stimulate COX1 translation is 
reduced when bound to Aac2p, then this could in turn help explain the relatively strong 
aac2A137D phenotype. However, since Mss51p overexpression failed to improve COX1 
translation when Aac2p activity was missing, this latter scenario appears unlikely. 
 The altered pattern of translation we observed is similar to what has been reported 
for loss of function mutants of the mitochondrial translation initiation factor, Aim23p; the 
DEAD-box helicase and mitochondrial transcription elongation factor, Mss116p; and the 
protein subunit of mitochondrial RNase P, Rpm2p, which is involved in mitochondrial 
RNA processing and mitochondrial translation (De Silva et al., 2017; Kuzmenko et al., 
2016; Stribinskis, Gao, Ellis, & Martin, 2001). We wondered if the absence of Aac2p 
function regulates mitochondrial translation in a way that is dependent on any of these 
mitochondrial proteins. Focusing on Aim23p, we asked if overexpression of this protein 
could rescue the impairment of mitochondrial translation that we observed in the absence 
of Aac2p function. Overexpression of Aim23p and Mss51p did not rescue the translation 
impairment suggesting that the absence of Aac2p function impacts mitochondrial 
translation in a way that does not involve either of these two proteins. Surprisingly, the 
98 
 
restored translation of complex IV subunits provided by overexpressed WT Aac2p was 
completely prevented by the inclusion of the Aac2p inhibitor, BKA. Since the chronic 
absence of Aac2p function significantly altered the mitochondrial ADP:ATP ratio (Figure 
2.1I), these results imply that Aac2p-based transport has an active and direct role in 
mitochondrial translation that may involve a feedback mechanism that is sensitive to 
matricial nucleotide levels. Even though some of the regulatory mechanisms that control 
mitochondrial translation are notably different between yeast and metazoans (Kehrein, 
Bonnefoy, & Ott, 2013), it will be important to determine if mitochondrial translation in 
humans is similarly dependent on mitochondrial ADP/ATP transport. If this requirement 
is conserved, then this could provide novel insight into ANT-associated diseases (Echaniz-
Laguna et al., 2012; Fontanesi et al., 2004; Graham et al., 1997; Jordens et al., 2002; 
Kaukonen et al., 2000; Komaki et al., 2002; Palmieri et al., 2005; Sharer, 2005; Thompson 





MATERIALS AND METHODS 
Yeast strains and growth conditions  
All yeast strains used in this study were derived from GA74-1A (MATa, his3-11,15, leu2, 
ura3, trp1, ade8 [rho+, mit+]). aac1Δ::TRP1 and aac3Δ::HISMX6 were established by 
replacing the entire open reading frame of the gene using PCR-mediated gene 
replacement(Wach, Brachat, Pöhlmann, & Philippsen, 1994). aac1Δaac3Δ (MATa, trp1, 
leu2, ura3, ade8, aac1Δ::TRP1, aac3Δ::HISMX6) was generated from aac1Δ (MATa, his3-
11,15, trp1, leu2, ura3, ade8, aac1Δ::TRP1). aac2Δ, aac2A137D, aac1Δaac3Δaac2Δ 
aac1Δaac3Δaac2A137D were generated from WT and aac1Δaac3Δ strains using 
Homology-integrated CRISPR-Cas (HI-CRISPR) system as previously described but with 
slight modification (Bao et al., 2015; Ogunbona, Onguka, Calzada, & Claypool, 2017). 
Briefly, the CRISPR-Cas9 target for AAC2 was selected using the web-based yeastriction 
(Mans et al., 2015) and Benchling CRISPR guide design tools. The CRISPR construct was 
designed to recognize residues 542-561 on the reverse strand of AAC2 (position 1 is the 
adenine of the AUG site). A 99bp or 250bp homology repair template was designed to have 
homology arms on both sides flanking the Cas9 cutting site and incorporated an 8bp 
deletion or point mutations to generate aac2Δ and aac2A137D, respectively. oma1Δ strains 
were generated from the corresponding parental strains as previously described (Ogunbona 
et al., 2017). 
Cox8p and Qcr10p, subunits of complex IV and III respectively were endogenously 
tagged in WT, aac2Δ, aac2A137D strains on the C-terminal end with 3X FLAG epitope tag 
using PCR-mediated gene replacement (Wach et al., 1994). COX5A and COX13 genomic 
sequence were amplified from GA74-1A yeast genomic DNA and cloned into pSP64. 
100 
 
Aac2p, Mss51F199Ip and Aim23p were overexpressed under the control of their native 
promoters in WT, aac2Δ, aac2A137D strains. AAC2 and AIM23 were amplified from 
genomic DNA isolated from GA74-1A yeast using primers that hybridized approximately 
380bp upstream of the predicted start codon and 140bp downstream of the predicted stop 
codon and cloned into pRS315 and pRS425 respectively. The constitutively active mutant 
form of MSS51 (MSS51F199I) (Barrientos et al., 2002; De Silva et al., 2017; Fontanesi et al., 
2011) was subcloned into pRS425. 
Yeast cells were grown in either YP-Sucrose (1% yeast extract, 2% peptone, 2% 
sucrose), YP-Dextrose (1% yeast extract, 2% peptone, 2% dextrose) or their synthetic (SC) 
media equivalent (containing 0.17% Yeast Nitrogen base minus amino acids, 0.5% 
Ammonium sulfate, 0.2% dropout mix containing required amino acids and 2% Sucrose or 
Dextrose). To assess the respiratory function of the different strains, overnight cultures 
grown in indicated media were spotted on solid media containing 2% dextrose or 
ethanol/glycerol (1% ethanol, 3% glycerol) and grown at 30oC. 
Measurement of Ascorbate-TMPD respiration rates 
Oxygen consumption rates were measured using a Clark-type oxygen electrode  as 
described before (Claypool et al., 2008), with some modifications. In brief, mitochondria 
(100 µg) were used as soon as possible after thawing on ice. 1 ml of respiration buffer (0.25 
M sucrose, 0.25 mg/ml BSA, 20 mM KCl, 20 mM Tris-Cl, 0.5 mM EDTA, 4 mM KH2PO4, 
and 3 mM MgCl2, pH 7.2) was added to a magnetically stirred 1.5 ml chamber with 
temperature controlled at 25°C and the signal representing the level of oxygen in the 
chamber allowed to equilibrate. Following addition of mitochondria, background 
respiration rate was recorded for about 30 seconds. Next, 1 mM ascorbate and 0.3 mM 
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TMPD were added simultaneously and the State 2 respiration recorded for 1 minute, before 
the addition of 50 μM ADP to initiate State 3 respiration. Once the added ADP was 
consumed, State 4 respiration was recorded for 2 minutes before 10 μM FCCP was added 
to induce uncoupling. Uncoupled respiration was measured for 2 minutes or until the 
oxygen level reached zero. As there is no ADP-stimulated respiration in the absence of 
Aac2p function, the basal respiration (State 2) and uncoupled respiration were calculated.  
Spectrophotometric Activity Assay 
Respiratory complex III and IV activities were measured as previously described (Dienhart 
& Stuart, 2008; Lu et al., 2017; Tzagoloff, Akai, & Needleman, 1975). Briefly, 5 µg of 
mitochondria solubilized in 0.5% (w/v) n-dodecyl β-D-maltoside (Anatrace) and spiked 
with protease inhibitors were added to reaction buffer (50 mM KPi, 2 mM EDTA, pH 7.4) 
with 0.08% (w/v) equine heart cytochrome c (Sigma). For complex III activity 
measurements, 1 mM KCN (prevents oxidation of cytochrome c by complex IV) and 100 
μM decylubiquinol (an analog of coenzyme Q) were added before the reaction was 
initiated. The reduction or oxidation of cytochrome c was followed at 550 nm. 
Mitochondrial ADP and ATP measurement 
Mitochondrial nucleotide levels were measured using ApoSENSOR ADP/ATP 
bioluminescent assay kit (BioVision) according to the manufacturer’s protocol. Briefly, 
luminescence of each crude mitochondrial sample was measured using a BMG Labtech 
Fluostar Omega microplate reader in the Luminescence mode. 50 μg of mitochondria were 
added to a mixture of ATP monitoring enzyme and nucleotide releasing buffer incubated 
at room temperature in a Greiner Bio-One Black flat-bottomed 96 well plate. To determine 
ATP level, luminescence values after 2 minutes of adding mitochondrial samples was 
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corrected by subtracting background luminescence. Thereafter, ADP converting enzyme 
that converts ADP to ATP was added and the ADP levels were determined as the change 
in luminescence after the converting enzyme was added.  
DNA Extraction and Quantitative Real-time PCR (qPCR) 
DNA was extracted as described (Hoffman, 2001). In brief, 15 units of A600 yeast cells 
grown for 24-48 hours in YP-Sucrose media were harvested, washed in sterile water and 
resuspended in 200 µl of breaking buffer (2% Triton X-100 (w/v), 1% SDS (w/v), 100 mM 
NaCl, 10 mM Tris pH 8.0, 1 mM EDTA pH 8.0). 0.3 g glass beads (~200-300 μl volume) 
and 200 μl phenol/chloroform/isoamyl alcohol was added and the tubes sealed with 
parafilm before vortexing at highest speed for 3 minutes. Next, 200 μl TE buffer pH 8.0 
was added and the mixture vortexed briefly before centrifugation at maximum speed at 
room temperature for 5 minutes. The aqueous phase was then transferred to a new 
eppendorf tube, 1 ml of 100% ethanol added and then mixed by inversion. This was 
followed by centrifugation at 21,000 x g at room temperature for 3 minutes and the pellets 
were resuspended in 400 μl Tris-EDTA (TE) buffer, pH 8.0. 3 μl of 10 mg/ml RNAse A 
was added followed by incubation at 37oC for 5 minutes before adding 10 µl of 4 M 
ammonium acetate and 1 ml 100% ethanol. Finally, DNA pellets were recovered by 
centrifugation at maximum speed at room temperature for 3 minutes, dried, and then 
resuspended in 30 µl TE buffer pH 8.0. The DNA were quantitated and stored at -80oC. 
Prior to the analyses, the DNA was re-quantitated and used at 10 ng/μl as template in the 
qPCR reaction. 
The FastStart Universal SYBR Green Master Rox (Roche) was used for qPCR 
performed according to the manufacturer’s instructions. 50 ng of genomic DNA was used 
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as template and the following primers were used at 100 nM concentration in a 20 µl 
reaction: COX1 forward, 5′- CTACAGATACAGCATTTCCAAGA-3′; COX1 reverse, 5′- 
GTGCCTGAATAGATGATAATGGT-3′; ACT1 forward, 5′- 
GTATGTGTAAAGCCGGTTTTG-3′; ACT1 reverse, 5′- 
CATGATACCTTGGTGTCTTGG -3′. The reaction was done in technical duplicate with 
three biological replicates. No-template controls were included in every assay. After 
completion of thermocycling cycles in a QuantStudio 6 Flex Real-Time PCR System 
(Thermo Fisher), melting-curve data were collected to verify PCR specificity and the 
absence of primer dimers. The Ct value difference between the nuclear (ACT1) and 
mitochondrial (COX1) target were computed as a measure of the level of mitochondrial 
DNA copy number relative to nuclear genome. A strain lacking its mitochondrial genome 
(Rho null) was used as negative control in all experiments. 
RNA Extraction and Reverse Transcription Quantitative Real-time PCR (RT-qPCR) 
Total RNA was extracted using hot phenol extraction exactly as described (Amin-ul 
Mannan, Sharma, & Ganesan, 2009) except that yeast cells were grown in YP-Sucrose 
media. Following treatment with Turbo DNase to remove any contaminating genomic 
DNA (TURBO DNA-free™ Kit, Invitrogen), RNA was purified using a RNeasy MiniElute 
Cleanup Kit (Qiagen). 1 µg of RNA was reverse transcribed into cDNA using 
SuperScript™ VILO™ Master Mix (Invitrogen) according to the manufacturer’s protocol. 
The qPCR was done as described above but using a 1:10 dilution of synthesized cDNA as 
template instead of genomic DNA. Additionally, we performed a minus-RT control, i.e. 
RNA not reverse-transcribed to cDNA to verify the absence of contaminating genomic 
DNA in RNA samples, in addition to a no-template control. TAF10 was used as a reference 
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gene (Teste, Duquenne, François, & Parrou, 2009). The primers used are TAF10 forward, 
5′- ATATTCCAGGATCAGGTCTTCCGTAGC -3′, TAF10 reverse, 5′- 
GTAGTCTTCTCATTCTGTTGATGTTGTTGTTG -3′; COX1 forward, 5′- 
TGCCTGCTTTAATTGGAGGT -3′, COX1 reverse, 5′- GGTCCTGAATGTGCCTGAAT 
-3′; COX2 forward, 5′- TTCAGGATTCAGCAACACCA -3′; COX2 reverse, 5′- 
CAGCTGGAAAAATTGTTCAAATA -3′; COX3 forward, 5′- 
TCTTTGCTGGTTTATTCTGAGC -3′; COX3 reverse, 5′- 
CTGCGATTAAGGCATGATGA -3′; ATP6 forward, 5′- 
CCTGCTGGTACACCATTACC -3′; ATP6 reverse, 5′- AGCCCAGACATATCCCTGAA 
-3′; ATP9 forward, 5′- TTGGAGCAGGTATCTCAACAAT -3′; ATP9 reverse, 5′- 
GCTTCTGATAAGGCGAAACC -3′. The Ct values difference between the reference gene 
(nuclear encoded TAF10) and the mitochondrial targets were computed as a measure of 
the steady state mRNA levels in the strains. A strain lacking its mitochondrial genome 
(Rho null) was used as negative control in all experiments. 
In Vivo Labeling of Mitochondrial Translation Products 
Yeast cells pre-cultured overnight in either YP-Sucrose (1% yeast extract, 2% peptone, 2% 
sucrose) or when strains are maintaining plasmids, synthetic media (containing 0.17% 
Yeast Nitrogen base minus amino acids, 0.5% Ammonium sulfate, 0.2% dropout mix 
containing amino acids except Leucine, and 2% Sucrose) were re-inoculated and grown to 
an A600 of 0.4-1. Yeast cells were labeled, prepared, and resolved by SDS-PAGE as done 
before (Barrientos et al., 2002) with little modification. In brief, 3.2 units of A600 yeast cells 
were washed with 2 ml of metabolic labeling buffer (40 mM KPi, pH 6.0, 2% Sucrose, 2 
g/L SC-Methionine) once and then incubated in the buffer for 5 minutes to allow 
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completion of in-progress translation. For BKA inhibition, the pH of the labeling buffer 
was adjusted to 5.0 with diluted HCl and BKA was added at 10 μM concentration.  0.2 
mg/ml of freshly prepared cycloheximide was then added to stop cytoplasmic translation, 
followed by the addition of 62 µCi/ml Trans 35S-Label (sku 015100907 MP Biomedical; 
85% Methionine and 15% Cysteine). Labeling was performed at 30oC in a water bath for 
up to 20 minutes. A mixture of non-radioactive 24.2 µM methionine and Cysteine (with 4 
µg/ml Puromycin in the chase) was added to stop the radiolabeling. After different time 
points, 0.5 ml aliquots were collected, processed in freshly prepared diluted Rodel buffer 
(0.24 M NaOH, 0.14 M 2-Mercaptoethanol, 1.3 mM phenylmethylsulfonyl fluoride) on 
ice, and then tricarboxylic acid (TCA)-precipitated. Recovered pellets were washed first 
with 500 mM Tris base and then with distilled water. The final pellet samples were 
resuspended in a 1:1 mixture of 0.1 M NaOH:2X reducing sample buffer and resolved on 
custom-made 17.5% SDS-PAGE (Barrientos et al., 2002) and/or 12-16% SDS-PAGE gels 
(the former as first described (Barrientos et al., 2002) gave better separation of all the 
mitochondrial proteins except Atp8p and Atp9p; however, using 2X more of Ammonium 
persulfate [APS] and N,N,N',N'-tetramethylethane-1,2-diamine [TEMED] i.e. 0.098% w/v 
and 0.071% v/v respectively, gave a 17.5% SDS-PAGE that provided for resolution of all 
the mitochondrial proteins as seen in Figures 2.7 C and E, 2.8A, 2.13A and 2.14A). Gels 
were stained with commassie, destained, dried, and separated radiolabeled proteins 
visualized by autoradiography. 
In organello import  
This was done as described before (Brandner et al., 2005; Ogunbona et al., 2017) with little 
modification. In brief, radiolabeled Cox5Ap and Cox13p precursors were synthesized in a 
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coupled transcription/translation reaction (Promega TNT Kit Mix) using 104 µCi of Easy-
Tag L-[35S] methionine (PerkinElmer Life Sciences) and 5.2 µg of plasmid in a 260 µl 
reaction volume. Mitochondria (180 µg) were added to import buffer (0.6 M Sorbitol, 2 
mM KH2PO4, 60 mM KCl, 50 mM HEPES, 10 mM MgCl2, 2.5 mM EDTA pH 8.0, 5 mM 
L-Methionine, 10 mg/mL Fatty Acid free BSA) containing 2 mM ATP, 2 mM NADH and 
an energy-regenerating system (0.1 mg/ml Creatine Phosphokinase, 1 mM Creatine 
phosphate, 10 mM Succinate). Where indicated, the mitochondrial membrane potential 
was collapsed with 1 μM valinomycin and 5 μM carbonyl cyanide m-chlorophenyl 
hydrazine. Following addition of the radiolabeled precursor, import reactions were 
incubated at 30oC. At the designated timepoints, import was stopped with an equal volume 
of ice-cold BB7.4 (0.6 M sorbitol and 20 mM HEPES-KOH, pH 7.4) that contained 40 
μg/ml of trypsin to degrade non-imported precursors. After at least 30 minutes on ice, 100 
μg/ml of soybean trypsin inhibitor was added to each reaction which were then split into 
two equal portions. To monitor import, mitochondria were recovered by spinning at 21,000 
× g for 5 min at 4°C and resolved on 15% SDS-PAGE gels. To monitor assembly, the re-
isolated mitochondria were solubilized in lysis buffer (1% (w/v) digitonin, 20 mM HEPE-
KOH, pH 7.4, 100 mM NaCl, 20 mM Imidazole, 1 mM CaCl2, 10% glycerol, 1 mM PMSF, 
10 μM leupeptin, 2 μM pepstatin A) and resolved on 5-12% blue native-PAGE gels. 
Relative to each timempoint, 5% of imported precursors were resolved on 15% SDS-PAGE 
gels. Radioactive bands were visualized by phosphorimaging. 
Antibodies 
Most antibodies used in this study were generated in our laboratory or in the laboratories 
of J. Schatz (University of Basel, Basel, Switzerland) or C. Koehler (UCLA) and have been 
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described previously (Claypool, Whited, Srijumnong, Han, & Koehler, 2011; Hwang, 
Claypool, Leuenberger, Tienson, & Koehler, 2007; Ogunbona et al., 2017; Onguka, 
Calzada, Ogunbona, & Claypool, 2015; Whited, Baile, Currier, & Claypool, 2013). Other 
antibodies used were rabbit polyclonal against Atp4p (Dienhart & Stuart, 2008), 
Atp6p/Atp9p(Kabala, Lasserre, Ackerman, di Rago, & Kucharczyk, 2014), 
Mss51p(Barrientos et al., 2002), Cox5Ap(Liu & Barrientos, 2013), Qcr7p(Hildenbeutel et 
al., 2014) and Aim23p(Kuzmenko et al., 2016). 
Miscellaneous 
Isolation of mitochondria, 1D BN-PAGE, co-immunoprecipitation and immunoblotting 
were performed as previously described (Claypool, Dickinson, Yoshida, Lencer, & 
Blumberg, 2002; Claypool, McCaffery, & Koehler, 2006; Claypool et al., 2011; Ogunbona 
et al., 2017; Onguka et al., 2015). Band densitometry analyses were performed using 
Quantity One (Bio-Rad). Statistical comparisons were performed by using one or two-way 
analysis of variance (ANOVA) with Dunnett test correction (Sidak’s test correction for 
data shown in Figures 2.8 C-H and 2.13 C-H) for multiple comparison in Prism 7 
(GraphPad); P ≤ 0.05 were deemed significant (ns P > 0.05; * P ≤ 0.05; ** P ≤ 0.01; *** P 
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Figure 2.1. A non-functional Aac2p mutant is expressed and assembled normally. (A) 
Whole cell extracts from the indicated yeast strains were resolved by SDS-PAGE and 
immunoblotted for Aac2p. (B) Growth of the indicated strains on dextrose or ethanol-
glycerol media at 30oC for 3 days. n=3. (C) – (E) Mitochondria (50 µg protein) solubilized 
in 1.5% (w/v) digitonin were resolved by 5-12% 1D Blue Native (BN)–PAGE and (C) 
Aac2p, (D) complex III (Rip1p) and (E) complex IV (Cox4p) detected by immunoblot. 
n=3. (F) Following solubilization with 1.5% (w/v) digitonin, anti-FLAG resin was used to 
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immunoprecipitate Cox8-3XFLAG (subunit of complex IV) and the presence of co-
purified respiratory supercomplex subunits determined by immunoblot; Kgd1p and 
Tom70p served as controls. SM, starting material; B, bound material; FT, non-binding flow 
through. n=3. *, non-specific bands. (G) ADP and (H) ATP levels in mitochondria. 
Luminescence values relative to wild type are shown. (I) Calculated mitochondrial 
ADP:ATP ratios. Mean ± SEM, n=4. Statistical difference relative to wild type is shown. 




Figure 2.2. Oxidative phosphorylation is impaired in the absence of Aac2p function.  
(A) Spectrophotometric measurement of complex IV activity in DDM-solubilized 
mitochondria. Mean ± SEM, n=6. (B) Basal and (C) uncoupled respiration (+CCCP) in 
intact mitochondria using ascorbate + TMPD (donate electrons to complex IV) as substrate. 
Mean ± SEM, n=6. (D) Spectrophotometric measurement of complex III activity in DDM-
solubilized mitochondria. Mean ± SEM, n=6. (E) Mitochondrial extracts were resolved by 
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SDS-PAGE and immunoblotted for various mitochondrial proteins- Kgd1p (matrix), 
Tom70p (outer membrane), Atp2p/Atp4p/Atp6p/Atp9p (Complex V), Pic1p (phosphate 
carrier) Cor2p/Rip1p/Qcr7p (Complex III), Cox1-4p/Cox5Ap (Complex IV), and Aac2p; 
*, non-specific band (F) Steady state levels of Cox1-4p, Qcr7p and Atp6p relative to WT 
were quantified. Mean ± SEM, n≥4.  Statistical difference relative to wild type is shown 




Figure 2.3. The regulation of mitochondrial genome encoded subunits of cytochrome 
c oxidase by Aac2p activity is post-transcriptional. (A) Boxplots showing mtDNA level 
in the indicated strains determined by quantitative polymerase chain reaction (qPCR) of 
COX1 in mtDNA and normalized to ACT1 in the nucleus. Whiskers represent 5th and 95th 
percentile. n=12 (B)–(F) Interleaved scatterplot showing the steady state transcript levels 
of mtDNA-encoded subunits determined by two step reverse transcription-quantitative 
PCR for Complex IV (COX1-3) and Complex V (ATP6, ATP9) subunits. TAF10 is a 
nuclear encoded reference gene. n≥3. The red dotted line refers to the calculated dCt values 






Figure 2.4. Aberrant mitochondrial translation in the absence of Aac2p function. (A) 
Yeast cultures were spiked with 62 μCi/ml 35S-methionine/cysteine and 0.2 mg/ml 
cycloheximide to inhibit cytosolic translation. After 10 and 20 minutes incubation at 30oC, 
extracts were harvested, resolved by 12-16% SDS-PAGE (Figure 2.11A), and bands 
identified by phosphoimaging. The distribution of signals from all the mitochondrial 
encoded translated proteins is expressed as a percentage of the total signal for each 
experiment. Mean ± SEM, n=10 for everything (this includes the t=0 timepoints presented 
in the pulse-chase experiments in (C) except Atp9p, n=5). Only statistically significant 
comparisons relative to WT are displayed. (B) The ratio of Cox3p to Atp6p signals was 
quantitated. Mean ± SEM, n=10. (C) After 20 mins of pulse, 4 µg/ml puromycin and 24.2 
µM methionine/cysteine were added and samples collected at t=0 and after 60 and 120 
minutes of chase. Extracts were resolved on 17.5% (top) and 12-16% (bottom) SDS-PAGE, 
and bands identified by phosphoimaging. n=5. (D) Key for quantitations presented in (E)-
(J). The relative signal for mitochondrial translated products in the pulse-chase experiment 
was quantified taking the signal at t=0 as 100%. Mean ± SEM, n=5. Significant differences 




Figure 2.5. Assembly of cytochrome c oxidase is not impaired in the absence of Aac2p 
function. (A) Schematic of complex IV assembly (McStay et al., 2013a; McStay et al., 
2013b; Su et al., 2014). An early assembly intermediate centered around Cox1p contains 
Cox5Ap. Cox13p is incorporated in the Cox3p-assembly module that is added later in the 
assembly process. Radiolabeled Cox5Ap (B and D) or Cox13p (C and E) was incubated 
with mitochondria from the indicated strains at 30°C and in the presence (+ΔΨ) or absence 
(-ΔΨ) of the electrochemical gradient across the inner membrane. Following incubation 
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for 5, 15, or45 minutes, non-imported precursors were removed with trypsin and the 
recovered mitochondria were resolved by 15% SDS-PAGE to monitor import (B and C) or 
solubilized in 1% (w/v) digitonin and resolved by BN–PAGE (D and E) to follow assembly 





Figure 2.6. Alteration of mitochondrial translation is rescued by overexpression of 
Aac2p. (A) Mitochondrial extracts (50 µg) were resolved by SDS-PAGE and 
immunoblotted for Mss51p (translational activator for the COX1 mRNA) and Aac2p. n=6. 
(B) Mitochondrial translation was performed as in Figure 2.4. After 10 and 20 minutes 
incubation at 30oC, extracts were harvested, resolved by 17.5% SDS-PAGE, and bands 
identified by phosphoimaging. n=3. (C) Mitochondrial extracts (50 µg) were resolved by 
SDS-PAGE and immunoblotted for Aim23p (mitochondrial translation initiation factor) 
and Aac2p. n=4. (D) Mitochondrial translation after 10 and 20 minutes incubation. 




Figure 2.7. Mitochondrial translation is altered by acute Aac2p inhibition. (A) 
Mitochondrial translation was performed in the absence or presence of 10 µM BKA. 
Samples were harvested after 10 and 20 minutes of incubation, resolved by 17.5% SDS-
PAGE, and bands identified by phosphoimaging. (B) The relative band intensities for the 
translated mitochondrial polypeptides in (A) were quantified and expressed as a ratio 
compared to the signal detected in the A137D strain transformed with empty vector (EV) 
in the absence of BKA.  Mean ± SEM, n=4. Only statistically significant differences 
relative to A137D + [EV] in absence of BKA are displayed. (C) Mitochondrial translation 
was performed in the absence or presence of 10 µM BKA. Samples were harvested after 
10 and 20 minutes incubation, resolved by 17.5% SDS-PAGE, and bands identified by 
phosphoimaging. (D) The relative band intensities for the translated mitochondrial 
polypeptides in (C) were quantified and expressed as a ratio compared to the signal 
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detected in the WT strain transformed with empty vector in the absence of BKA.  Mean ± 
SEM, n=4. Only statistically significant differences relative to WT + [EV] in absence of 




Figure 2.8. The stability of nascent Cox3p is reduced by acute Aac2p inhibition. (A) 
Mitochondrial translation was performed in the absence or presence of 10 µM BKA. After 
20 mins of pulse, 4 µg/ml puromycin and 24.2 µM methionine/cysteine were added and 
samples collected at t=0 and after 60 and 120 minutes of chase. Extracts were resolved on 
17.5% SDS-PAGE, and bands identified by phosphoimaging. (B) Key for quantitations 
presented in (C-H). The relative signal for mitochondrial translated products in the pulse-
chase experiment was quantified taking the signal at t=0 as 100%. Mean ± SEM, n=4. 
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Significant differences (as determined by two-way ANOVA with Sidak’s multiple 




Figure 2.9. Epitope-tagged complex III and IV subunits are functional and 
assemble/associate normally. (A) Following solubilization with 1.5% (w/v) digitonin, 
anti-FLAG resin was used to immunoprecipitate Qcr10-3XFLAG (subunit of complex III) 
and the presence of co-purified respiratory supercomplex subunits determined by 
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immunoblot; Kgd1p and Tom70p served as controls. SM, starting material; B, bound 
material; FT, non-binding flow through. n=3. (B) Whole cell extracts for the indicated yeast 
strains were resolved by SDS-PAGE and immunoblotted for the indicated protein: Tom70p 
(outer membrane), Tim54p (inner membrane), Atp2p/Atp4p (Complex V), Pic1p 
(phosphate carrier), Cor2p/Rip1p (Complex III), Cox1p/Cox4p (Complex IV) and Aac2p. 
n=3. (C) Growth of the indicated strains on dextrose or ethanol-glycerol media at 30oC for 
3 days. n=3. (D) – (G) Mitochondria (50 µg protein) solubilized in 1.5% (w/v) digitonin 
were resolved by a 5-12% 1D BN–PAGE (D) Aac2p, (E) complex III (Rip1p), (F) complex 




Figure 2.10. Steady states level of most mitochondrial proteins are not affected by 
Aac2p activity. (A) Steady state levels of Kgd1p, Tom70p, Pic1p, Atp2p, Atp4p, Atp9p, 
Rip1p, Cor2p, Cox5Ap and Aac2p, shown in Figure 2E, relative to WT are quantified. 




Figure 2.11. Aberrant mitochondrial translation in the absence of Aac2p function. (A) 
Yeast cultures were spiked with 62 μCi/ml 35S-methionine/cysteine and 0.2 mg/ml 
cycloheximide to inhibit cytosolic translation. After 10 and 20 minutes incubation at 30oC, 
extracts were harvested, resolved by 12-16% SDS-PAGE, and bands identified by 
phosphoimaging. Quantification is shown in Figure 2.4A. (B) The incorporation of 35S 
into Var1p for indicated strains was expressed relative to WT. Mean ± SEM, n=10. There 
was no statistically significant difference in the Var1p labeling among the strains. (C) The 
total incorporation of 35S into all mitochondrial translated polypeptides was summed and 
expressed relative to WT. Mean ± SEM, n=10. There was no statistically significant 





Figure 2.12. Mitochondrial translation is altered by acute Aac2p inhibition. Whole 
cell extracts for the indicated yeast strains were resolved by SDS-PAGE and 
immunoblotted for (A) Mss51p (translational activator for the COX1 mRNA) or (B) 
Aim23p (mitochondrial translation initiation factor); Tom70p served as loading control. 
n=4. (C) Whole cell extracts for the indicated yeast strains were resolved by SDS-PAGE 
and immunoblotted for the indicated protein- Tom70p (outer membrane), Cox3p/Cox5Ap 
(complex IV). n=5.  
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Figure 2.13. Turnover of synthesized mitochondrial protein upon acute Aac2p 
inhibition in the plasmid-based setting. (A) Mitochondrial translation in the absence or 
presence of 10 µM BKA. After 20 mins of pulse, 4 µg/ml puromycin and 24.2 µM 
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methionine/cysteine were added and samples collected at t=0 and after 60 and 120 minutes 
of chase. Extracts were resolved on 17.5% SDS-PAGE, and bands identified by 
phosphoimaging. (B) Key for quantitations presented in (C)-(H). (C)-(H) The relative 
signal for mitochondrial translated products in the pulse-chase experiment was quantified 
taking the signal at t=0 as 100%. Mean ± SEM, n=4. Significant differences (as determined 
by two-way ANOVA with Sidak’s multiple comparison test) of the percent remaining at 




Figure 2.14. Plasmid maintenance reduces mitochondrial translation and decreases 
the stability of newly translated Cox3p when Aac2p is functional. (A) After 20 mins of 
pulse, 4 µg/ml puromycin and 24.2 µM methionine/cysteine were added and samples 
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collected at t=0 and after 60 and 120 minutes of chase. Extracts were resolved on 17.5% 
SDS-PAGE, and bands identified by phosphoimaging. (B) Key for quantitations presented 
in (C-H). The relative signal for mitochondrial translated products in the pulse-chase 
experiment was quantified taking the signal at t=0 as 100%. Mean ± SEM, n=2. No 




Figure 2.15. OMA1 disruption does not rescue the steady states level of complex IV 
subunits. Whole cell extracts for the indicated yeast strains were resolved by SDS-PAGE 
and immunoblotted for the indicated protein: Kgd1p(matrix), Tom70p (outer membrane), 
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Solute carrier and Mitochondrial Carrier Family 
The MCF is a big family of proteins with members serving a lot of metabolic 
functions with numerous pathophysiologic implications. Several members have emerging 
roles in the biogenesis of cytochrome c oxidase. My thesis work uncovered a novel 
mitochondrial translation-dependent mode of regulation that tightly links complex IV 
expression to Aac2p transport activity.  Additional studies are needed to probe the 
molecular details of the regulation provided by other members that have been linked to 
cytochrome c oxidase biogenesis and determine if a similar regulatory mechanism exists 
in humans. 
Translation-dependent regulation of cytochrome c oxidase 
A long standing enigma in the field of mitochondrial biology has been the 
molecular mechanisms for the regulation of cytochrome c oxidase activity by Aac2p 
(Claypool, Oktay, Boontheung, Loo, & Koehler, 2008; Dienhart & Stuart, 2008; Fontanesi 
et al., 2004; Heidkämper, Müller, Nelson, & Klingenberg, 1996; Müller, Basset, Nelson, 
& Klingenberg, 1996). Given the recently discovered interaction between Aac2p and RSCs 
(Claypool et al., 2008; Dienhart & Stuart, 2008), the major goal of my dissertation work 
was to understand whether Aac2p function and/or its interaction with RSCs is important 
for optimal complex IV activity. Interestingly, we found a role for Aac2p in the optimal 
translation of mitochondrial genome encoded subunits of cytochrome c oxidase (Figure 
2.4). While this provides an explanation for the regulation of the complex’s activity, it also 
functionally links nucleotide transport/metabolism to mitochondrial translation and the 
discovery opens up further lines of inquiry. 
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It is still unclear what the direct connection between Aac2p function and complex 
IV biogenesis pathway is. Perhaps the connection is a direct consequence of an altered 
ADP/ATP ratio in the mitochondrial matrix (Figure 2.1I). Further experiments are needed 
to test this hypothesis. It will be important to ascertain how the ADP and ATP levels in the 
mitochondrial matrix correlate with mitochondrial translation inhibition brought about by 
BKA. Measuring ATP and ADP levels in the mitochondria directly could be done using 
live-cell reporting with a fluorescent biosensor such as PercevalHR (Tantama, Martínez-
François, Mongeon, & Yellen, 2013) which can be further modified to direct it to the 
mitochondrial matrix thus enabling one to monitor nucleotide changes in this compartment 
in real time.   
It is also unclear as to why the translation of the subunits of the ATP synthase 
(complex V) are increased in the absence of Aac2p function. It could be a compensatory 
mechanism since assembly of respiratory complexes are linked to their synthesis. Also 
interesting is that the increase in the translational synthesis of the ATP synthase subunits 
is not reflected at the steady state level, at least for Atp6p and Atp9p (Figure 2.2E). The 
activity of the ATP synthase has also not been measured so it is unknown if there is a 
concomitant increase in the activity of the complex. While it appears that the assembly of 
synthesized complex IV subunits into the holoenzyme is not impaired, it is presently 
unknown why Cox5Ap incorporation into the respiratory complexes is increased in the 
absence of Aac2p compared to wild type and the non-functional Aac2p strains (Figure 
2.5D). 
Cox3p stability appears to be compromised in strains expressing the non-functional 
Aac2p, Aac2A137D (Figure 2.4G). The reason for this is presently elusive and could be due 
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to the action of a mitochondrial protease. We initially focused on Oma1p, a mitochondrial 
protease that has been shown to degrade unassembled complex IV subunits in many 
different settings (Bestwick, Khalimonchuk, Pierrel, & Winge, 2010; Khalimonchuk, 
Jeong, Watts, Ferris, & Winge, 2012). However, Oma1p ablation did not rescue the level 
of affected cytochrome c oxidase subunits (Figure 2.15). Nevertheless, it is possible that 
other mitochondrial proteases are involved. In particular, the two ATP-dependent proteases 
of the IM and the mitochondrial matrix, the i-AAA (Yme1/Mgr protein complex) and m-
AAA proteases (Yta10/12 complex) respectively, warrant further investigation given their 
pre-eminent roles in enforcing mitochondrial quality control on either side of the IM.  
Why would the COX subunit be turned over faster in the absence of Aac2p 
function? Potentially, the augmented rate of Cox3p degradation reflects the existence of a 
novel ATP dependent step in the COX assembly pathway. Alternatively, perhaps the 
stability of newly synthesized Cox3p subunit(s) is itself energy demanding. Will 
elimination of the protease restore the steady state levels and possibly increase the amount 
and activity of cytochrome c oxidase? Mitochondrial proteases are important quality 
control machinery and their role in this regard has been extensively reviewed (Baker, 
Tatsuta, & Langer, 2011; Fischer, Hamann, & Osiewacz, 2012). Recently, we uncovered a 
role for Yme1p and Oma1p in enforcing quality control of a mitochondrial lipid 
synthesizing enzyme, Psd1p (Ogunbona, Onguka, Calzada, & Claypool, 2017). This 
interesting story is appended as Chapter 4 of this work. 
Finally, in mammals, the multiple ANT isoforms (ANT1-4) have tissue-specific expression 
although their biological roles in the different tissues have not be defined. It will thus be 
important to determine the role and contribution of each ANT isoforms to OXPHOS 
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regulation and whether the dependence of mitochondrial translation and complex IV 
biogenesis on nucleotide transport that we discovered in yeast similarly occurs in the 
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Phosphatidylserine decarboxylase 1 (Psd1p), an ancient enzyme that converts 
phosphatidylserine to phosphatidylethanolamine in the inner mitochondrial membrane, 
must undergo an autocatalytic self-processing event to gain activity. Autocatalysis severs 
the protein into a large membrane anchored β subunit that non-covalently associates with 
the small α subunit on the intermembrane space side of the inner membrane. Here, we 
determined that a temperature sensitive (ts) PSD1 allele is autocatalytically impaired and 
that its fidelity is closely monitored throughout its life cycle by multiple mitochondrial 
quality control proteases. Interestingly, the proteases involved in resolving misfolded 
Psd1ts vary depending on its autocatalytic status. Specifically, the degradation of a Psd1ts 
precursor unable to undergo autocatalysis requires the unprecedented cooperative and 
sequential action of two inner membrane proteases, Oma1p and Yme1p. In contrast, upon 
heat-exposure post-autocatalysis, Psd1ts β subunits accumulate in protein aggregates that 
are resolved by Yme1p acting alone while the released α subunit is degraded in parallel by 
an unidentified protease. Importantly, the stability of endogenous Psd1p is also influenced 
by Yme1p. We conclude that Psd1p, the key enzyme required for the mitochondrial 
pathway of phosphatidylethanolamine production, is closely monitored at several levels 
and by multiple mitochondrial quality control mechanisms present in the intermembrane 
space. 







In an aqueous environment, the amphipathic chemistry of phospholipids drives the 
formation of lipid bilayers. These bilayers encapsulate the cell and its internal 
compartments and are indispensable for life. As one of the major membrane phospholipids, 
phosphatidylethanolamine (PE) is of fundamental importance for cell physiology with 
numerous emerging links to human pathology. PE serves as a precursor to the major 
cellular phospholipid, phosphatidylcholine (Summers, Letts, McGraw, & Henry, 1988) and 
is a critical component of glycosylphosphatidylinositol anchors (Menon & Stevens, 1992), 
the cleavage furrow (Emoto et al., 1996), and autophagy (Ichimura et al., 2000). In bacteria, 
PE can dictate membrane protein topology and function (Bogdanov & Dowhan, 2012). 
Defects in PE levels have been linked to Alzheimer’s (Nesic et al., 2012), Parkinson’s 
(Wang et al., 2014), and liver diseases (van der Veen, Lingrell, da Silva, Jacobs, & Vance, 
2014). In spite of its clear physiologic importance, there remain significant gaps in our 
basic understanding of PE metabolism, including detailed mechanistic information 
concerning the enzymes responsible for its synthesis. 
Of the four cellular pathways of PE production, two are essential for mammalian 
development and are differentially localized to the endoplasmic reticulum (ER) or the 
mitochondrion (Fullerton, Hakimuddin, & Bakovic, 2007; Steenbergen et al., 2005). The 
role of mitochondria in lipid synthesis is rarely mentioned despite the fact that it is second 
only to the ER in this functional capacity. Phospholipids made in the mitochondrion are 
phosphatidic acid (PA), cytidine diphosphate-diacylglycerol, phosphatidylglycerol, 
cardiolipin (CL), and PE (Lu & Claypool, 2015; Osman, Voelker, & Langer, 2011). Yeast 
express two phosphatidylserine decarboxylases, Psd1p and Psd2p, which produce PE by 
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decarboxylating phosphatidylserine (PS). Psd1p is localized in the mitochondrion (Y. 
Tamura et al., 2012; Trotter, Pedretti, & Voelker, 1993) while Psd2p resides in the 
endomembrane system (Gulshan, Schmidt, Shahi, & Moye-Rowley, 2008; Trotter & 
Voelker, 1995). Psd1p is conserved from bacteria to humans while Psd2p is only found in 
yeast. Yeast lacking both Psd1p and Psd2p (psd1Δpsd2Δ) are ethanolamine auxotrophs 
and require ethanolamine supplementation to produce PE by the ER localized CDP-
ethanolamine pathway, the second major cellular pathway of PE biosynthesis.  
Psd1p is encoded within the nucleus and imported into the mitochondrion post-
synthesis as a zymogen (Trotter et al., 1993). Its maturation requires three proteolytic 
processing steps, the last of which is executed by Psd1p itself and essential to generate an 
active decarboxylase. This self-processing event, termed autocatalysis, separates the 
enzyme into two subunits, α and β, and generates a pyruvoyl prosthetic group at the NH2-
terminus of the α subunit that is absolutely required for enzymatic activity (Li & Dowhan, 
1988, 1990; Satre & Kennedy, 1978). Autocatalysis occurs within a conserved LGST motif 
between the glycine and the serine residues through a process of serinolysis (Choi, 
Augagneur, Ben Mamoun, & Voelker, 2012; Horvath et al., 2012; Kuge, Saito, Kojima, 
Akamatsu, & Nishijima, 1996; Li & Dowhan, 1988, 1990; Onguka, Calzada, Ogunbona, 
& Claypool, 2015). The α subunit remains non-covalently associated with the β subunit, 
which is anchored to the mitochondrial inner membrane so that PS decarboxylation occurs 
on the intermembrane space (IMS) side (Horvath et al., 2012). Aside from the conserved 
LGST motif, mechanistic insight into this essential self-cleaving event is limited. 
We recently showed that Psd1p re-routed to the secretory pathway undergoes 
autocatalysis normally and is capable of rescuing the ethanolamine auxotrophy of 
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psd1Δpsd2Δ yeast (Onguka, Calzada, Ogunbona, & Claypool, 2015). As such, unique 
mitochondrial factors–protein, lipid, or other–are not required for Psd1p autocatalysis. 
Thus, as long as it is anchored in a membrane, everything that is needed for Psd1p 
autocatalysis is encoded within the polypeptide itself. Based on these results, we 
hypothesized that membrane anchorage of Psd1p promotes a tertiary structure that is 
critical for autocatalysis. As such, mutations outside the conserved LGST motif that disrupt 
this postulated structure would be predicted to impair autocatalysis.  
With the goal of identifying novel motifs required for Psd1p autocatalysis and 
function, we investigated the molecular basis of the temperature-sensitive behavior of a 
PSD1 allele (Psd1ts) that has four missense mutations in the β subunit (Birner, Nebauer, 
Schneiter, & Daum, 2003). We hypothesized that the temperature sensitivity of Psd1ts was 
due to a defect in autocatalysis which we demonstrate to indeed be the case. Our additional 
results indicate that the fidelity of Psd1ts is closely monitored by multiple mitochondrial 
quality control proteases. Interestingly, the efficient degradation of the Psd1ts precursor 
requires the sequential activity of two distinct proteases with Oma1p working prior to 
Yme1p. In contrast, post-autocatalysis, Yme1p, which is not required for the rapid turnover 
of the small α subunit, is able to degrade the mature Psd1ts β subunit alone. We conclude 
that key enzyme required for the mitochondrial pathway of phosphatidylethanolamine 
production, Psd1p, is closely monitored at several levels and by multiple mitochondrial 
quality control mechanisms present in the IMS. These results further underscore the 
efficiency and dedication of the quality control machinery towards the preservation of 





Defective autocatalysis of a temperature sensitive PSD1 allele 
Using error prone PCR, a temperature sensitive (ts) PSD1 allele was previously 
established that has a growth defect at the non-permissive temperature of 37oC (Birner et 
al., 2003). Psd1ts harbors four missense mutations – K356R, F397L, E429G, and M448T– 
in the β subunit (Figure 4.1A). However, the molecular basis for the thermolability of Psd1ts 
has never been established. We hypothesized that the introduced mutations may disrupt 
Psd1p autocatalysis at the restrictive temperature which would in turn prevent it from 
functioning in mitochondrial PE synthesis. Consistent with the original characterization of 
the ts allele (Birner et al., 2003), Psd1ts supported growth of the psd1Δpsd2Δ strain in the 
absence of ethanolamine at 22oC and 30oC, but failed to do so at 37oC (Figure 4.1B). Wild 
type (WT) Psd1p rescued growth of psd1Δpsd2Δ yeast in the absence of ethanolamine at 
all temperatures. Consistent with our hypothesis, whereas WT Psd1p was properly matured 
into separate β and α subunits following growth at each temperature, Psd1ts had a mild 
autocatalytic defect at permissive temperature (22oC) that was exacerbated at 30oC. 
Following overnight growth at the restrictive temperature (37oC), even the Psd1ts precursor 
was not detected by immunoblot (Figure 4.1C). Interestingly, even though Psd1ts α and 
mature β subunits were not detected by immunoblot when grown at 30oC (Figure 4.1C), 
there is apparently still enough functional enzyme present to rescue the ethanolamine 
auxotrophy of the psd1Δpsd2Δ strain at this temperature (Figure 4.1B). Indeed, an analysis 
of mitochondrial phospholipids revealed that Psd1ts significantly increased PE levels 
relative to the parental psd1Δpsd2Δ strain following overnight growth at 22oC and 30oC, 
but not at 37oC (Figure 4.1, D and E). 
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Next, radiolabeled WT and ts Psd1 precursors were incubated with wild type 
mitochondria and their import and processing followed as a function of time, temperature 
(22oC, 30oC, or 37oC), and the presence and absence of a membrane potential (Figure 4.1F). 
Psd1p precursor harboring a S463A mutation in the conserved LGST motif served as an 
autocatalysis-defective control (Onguka et al., 2015). As expected, WT Psd1p was 
imported into mitochondria and underwent autocatalysis in a time and membrane-potential 
dependent manner at every temperature tested. In contrast, Psd1ts was imported into 
mitochondria but failed to undergo autocatalysis at any temperature. Thus, in organello 
import studies of Psd1ts revealed a severe defect in autocatalysis even when incubated at 
what is a permissive temperature in vivo. We conclude that the four mutations introduced 
into the β subunit of the ts allele inactivate Psd1p function at the restrictive temperature by 
disrupting its autocatalysis. 
Psd1p is a self-processing serine protease before becoming a decarboxylase  
The fact that ER-targeted Psd1p undergoes autocatalysis and is functional in vivo 
(Onguka et al., 2015) indicates that everything needed for autocatalysis is self-contained 
within the polypeptide. Currently, the only structural motif that is known to be required for 
autocatalysis across many species is the conserved LGST motif (Choi et al., 2012; Horvath 
et al., 2012; Kuge et al., 1996; Li & Dowhan, 1988, 1990; Onguka et al., 2015). A 
fundamental question regarding the autocatalytic mechanism is what makes Ser463 of the 
LGST motif a strong nucleophile. We postulated that Psd1p serinolysis involves a catalytic 
triad consisting of an acid and a base present within the polypeptide. Indeed, three bases 
(His residues, green) and twelve acids (Asp, Asn, Glu, and Gln) are conserved in the β 
subunit of Psd1p from bacteria to humans (Figure 4.2A). Of the three conserved bases, 
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only mutation of His345 prevented autocatalysis (Figure 4.2B) and failed to support growth 
of the psd1Δpsd2Δ strain in the absence of ethanolamine (Figure 4.2C). Interestingly, 
His345 is flanked by the four mutations present in the ts allele (Figure 4.2A, red dashes) 
suggesting a plausible mechanism for how they disturb the autocatalytic process. Similar 
to the H345A and S463A mutants, a D210A Psd1p mutant was autocatalytically impaired 
and nonfunctional (Figure 4.2, D and E). These results suggest that Ser463-His345-Asp210 
of yeast Psd1p form a catalytic triad typical of serine proteases. In sum, Psd1p initially 
functions as a self-processing serine protease whose activity unmasks its final PS 
decarboxylase activity. 
Psd1ts is an unstable polypeptide with destabilized intramolecular interactions 
The mutations in Psd1ts disturbed the autocatalytic process before it occurred. We 
wondered if these same mutations could disrupt Psd1ts when shifted to the restrictive 
temperature post-autocatalysis. To determine the relative stability of WT and ts Psd1p at 
different temperatures, in vivo degradation assays were performed (Figure 4.3A). 
Following growth at permissive temperature to allow autocatalysis of Psd1ts, 
cycloheximide was added to inhibit new cytosolic protein synthesis and the cultures were 
either maintained at 22oC or shifted to 30oC or 37oC prior to ascertaining the abundance of 
Psd1p α and β subunits at varying times by immunoblot. Wild type Psd1p α and β subunits 
were relatively stable at each temperature (Figure 4.3, B-E). At permissive temperature, 
both Psd1ts subunits were stable similar to WT Psd1p (Figure 4.3, B and C). In contrast, 
upon shifting to 30oC or 37oC, the stability of both Psd1ts subunits was significantly 
reduced compared to WT Psd1p (Figure 4.3, B, D, and E). Interestingly, at 37oC the α 
subunit of Psd1ts disappeared faster than its β subunit. To extend these results, mitochondria 
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isolated from psd1Δpsd2Δ yeast grown at permissive temperature and expressing either 
WT or ts Psd1p were incubated at 30oC or 37oC for up to an hour prior to determining the 
levels of Psd1p α and β subunits by immunoblot (Figure 4.3, F-H). As observed in vivo 
(Figure 4.3, B and E), the steady state abundance of the Psd1ts α subunit decreased more 
rapidly at 37oC than the β subunit, which was itself less stable than its WT counterpart 
(Figure 4.3H). This suggests that at higher temperature the Psd1ts β subunit might be 
partially unfolded leading to the release of the α subunit. Further, these results implicate 
mitochondrial proteases in the temperature-dependent reduction in Psd1ts levels. 
To begin to assess the folding status of Psd1ts, a blue native-PAGE (BN-PAGE) 
analysis was performed. BN-PAGE is a gentle electrophoretic technique that can resolve 
intact protein complexes, thus providing information on the quaternary structure of a 
protein. Post-autocatalysis, the α and β subunits of Psd1p remain non-covalently 
associated.  Consistent with this, both the α and β subunits of WT Psd1p co-migrated in a 
discrete complex of >669 kDa (Figure 4.4A, red arrows in the top panels) and as diffuse 
complexes centered around 140 kDa (Figure 4.4A, red lines in the top panels). In contrast, 
Psd1ts α subunit-containing complexes were absent which caused the Psd1ts β subunit-
containing complexes to be slightly downshifted compared to WT (Figure 4.4A, gray lines 
in the top right panel). Given that its steady state abundance as determined following SDS-
PAGE was similar to WT Psd1p (Figure 4.4A, bottom panels), the failure to detect Psd1ts 
α subunit-containing complexes indicates that the Psd1ts β and α subunit interaction is 
destabilized in BN-PAGE. Since the α subunit is only ~10 kDa, it would not likely be 
resolved in this gel system. To directly determine if the non-covalent interaction between 
the α and β subunits of Psd1ts post-autocatalysis is impaired, 3XFLAG tagged Psd1p α was 
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immunoprecipitated from mitochondria isolated from yeast grown at permissive 
temperature and the presence of co-purified β subunit determined (Figure 4.4B). Indeed, in 
contrast to WT Psd1p, the β subunit of the ts allele was only weakly co-purified with the α 
subunit and a significant fraction of Psd1ts β was instead detected in the unbound flow thru 
(Figure 4.4C). These results indicate that the interaction of the α and β subunits of Psd1ts 
is compromised even at permissive temperature. 
The α and β subunits are co-dependent  
At elevated temperatures, the α subunit of Psd1ts exhibited a faster rate of decay 
than the β subunit (Figure 4.3, E and H) suggesting that post-autocatalysis, the α subunit 
requires the β subunit for its stability. Whether the WT β subunit requires the α subunit for 
its stability has not been established. Therefore, we generated in vivo constructs that allow 
the α and the β subunits to be expressed separately (Figure 4.5A); the former targeted to 
the mitochondrial IMS using the mitochondrial targeting sequence from Cytochrome c1 
(Glick et al., 1992). The constructs were either individually or in combination transformed 
into psd1Δpsd2Δ yeast. Whereas the α subunit was readily detected when expressed 
individually, the β subunit was virtually undetectable (Figure 4.5B). The failure of the β 
subunit to accumulate was not secondary to a defect in its mitochondrial import (Figure 
4.5D). Interestingly, when both subunits were co-expressed, the steady state abundance of 
the β subunit was somewhat stabilized. To more rigorously test the ability of the α subunit 
to promote the stability of Psd1β in trans, psd1Δpsd2Δ yeast expressing Psd1β were re-
transformed with either a plasmid encoding the IMS-directed α subunit subject to 
doxycycline repression or empty vector (Figure 4.5E). In this model, Psd1β levels were 
directly proportional to the amount of co-expressed IMS-α (Figure 4.5F). Since the 
catalytically essential pyruvoyl prosthetic group is generated by the autocatalytic process, 
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artificial separation of the two subunits, even if brought back together physically, failed to 
rescue growth of the psd1Δpsd2Δ strain in the absence of ethanolamine, as expected 
(Figure 4.5, C and G). Finally, we determined whether the capacity of IMS-α to promote 
the stability of Psd1β reflected their ability to physically interact in trans. Consistent with 
the idea that IMS-α promotes Psd1β stability through their non-covalent association, Psd1β 
was co-purified with 3XFLAG tagged IMS-α (Figure 4.5H). Interestingly, the ability of 
digitonin to extract Psd1β was improved when co-expressed with IMS-α (Figure 4.5I). The 
failure of digitonin to solubilize Psd1β when expressed in isolation could reflect its folding 
status and/or accumulation in insoluble protein aggregates. Taken together, these results 
indicate that pre-autocatalysis the β subunit requires the α subunit for its stability while 
post-autocatalysis, they are mutually co-dependent. 
The i-AAA protease degrades Psd1ts β subunit following its heat-induced aggregation  
Yme1p forms the i-AAA protease which has a principal role in enforcing quality 
control within the mitochondrial IMS (Potting, Wilmes, Engmann, Osman, & Langer, 
2010; Schreiner et al., 2012). It was previously reported that deletion of YME1 augments 
Psd1p activity with a concomitant increase in mitochondrial PE levels (Nebauer, Schuiki, 
Kulterer, Trajanoski, & Daum, 2007). From these results it was postulated that Yme1p 
contributes to the proteolytic turnover of Psd1p although direct evidence of this was never 
provided. To ascertain if Yme1p is a determinant of Psd1p stability, YME1 was deleted in 
the context of psd1Δpsd2Δ yeast expressing a given amount of WT or ts Psd1p (Figures 
4.6A). Next, the expression of WT or ts Psd1p was compared following growth at 22oC, 
30oC, and 37oC in the presence or absence Yme1p (Figure 4.6B). Notably, in the absence 
of Yme1p, both WT and ts Psd1p precursor accumulated at every temperature (Figure 
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4.6B, β-α band detected by both antibodies) and the amount of WT α and β subunits 
detected at 37oC was increased. The absence of Yme1p modestly rescued the autocatalytic 
defect of Psd1ts at 30oC but not 37oC; at 37oC three smaller COOH terminal containing 
Psd1ts fragments accumulated (f1, f2, and f3). Deletion of Yme1p did not change the 
thermosensitivity of Psd1ts (Figure 4.6C) or its assembly (Figure 4.6, D-F). These results 
suggest a role for Yme1p in Psd1p biogenesis, indicate that at elevated temperatures a 
fraction of WT Psd1p is degraded by Yme1p, and demonstrate that several Psd1ts fragments 
are produced independent of Yme1p which is responsible for their normal removal.  
When the temperature-dependent stability of WT and ts Psd1p was assessed post-
autocatalysis in vivo, a striking Yme1p-dependent difference in the thermostability of the 
β and α subunits of Psd1ts was identified (Figures 4.7, A-C). In the presence of Yme1p, the 
β and α subunits of Psd1ts were degraded at roughly similar rates at elevated temperatures 
(α slightly faster than β as previously noted). However, in its absence, while the α subunit 
still rapidly disappeared at higher temperatures, the Psd1ts β subunit was significantly 
stabilized (Figures 4.7, B and C). Importantly, the discordant behavior of the α and β 
subunits of Psd1ts minus Yme1p was also observed upon in vitro incubation of isolated 
mitochondria at 37oC (Figures 4.8, A-C). Yme1p has a documented role in resolving 
mitochondrial protein aggregates (Schreiner et al., 2012). Therefore, we speculated that at 
elevated temperatures, the folding of Psd1ts β may be affected such that its interaction with 
α is compromised causing it to adopt an aggregation-prone state. To test this idea, the α/β 
association and aggregation state of WT and ts Psd1p was determined in isolated 
mitochondria kept on ice or incubated as indicated at 37oC. The α/β association of WT and 
ts Psd1p was not noticeably affected at elevated temperatures although less total Psd1ts α 
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and co-purified β was noted after 20min at 37oC (Figure 4.8D). In the presence or absence 
of Yme1p, WT Psd1p (both subunits) was almost completely extracted by digitonin even 
following a 1 hr heat treatment (Figures 4.8, E-G). In contrast, whereas both ts subunits 
were readily solubilized by digitonin in the presence or absence of Yme1p when kept on 
ice, after only 1 hr at 37oC, a significant fraction of Psd1ts β, but not α, accumulated in TX-
100 resistant protein aggregates (red arrowheads in Figure 4.8E, quantified in F and G). 
Surprisingly, the heat-induced aggregation of Psd1ts β occurred even in the context of 
Yme1p. Given that the levels of the ts β subunit were decreased by ~ 77% after only 2hrs 
growth at 37oC (Figure 4.3E), this suggests that aggregation of Psd1ts β proceeds, and likely 
provokes, its ultimate removal by Yme1p. Taken together, our results support the following 
model (Figure 4.8H): Upon exposure to heat, Psd1ts β subunits are partially denatured such 
that they rapidly accumulate in protein aggregates that are eventually resolved by Yme1p. 
The Psd1ts β aggregates do not include the α subunit which is instead rapidly degraded by 
an unidentified mitochondrial protease upon its release from β. 
Evidence of role for Yme1p in the life cycle of endogenous Psd1p 
 We sought to obtain evidence for the involvement of Yme1p in the stability and/or 
folding of endogenous Psd1p. Since the levels of WT α and β subunits detected at 37oC 
was increased in the absence of Yme1p (Figure 4.6B), we first determined the expression 
of endogenous Psd1p following growth of WT and yme1Δ yeast at 30oC and 37oC (Figure 
4.9A).  
Next, we determined the aggregation status of endogenous Psd1p in WT and yme1Δ 
mitochondria isolated following growth at 30oC or 37oC in the presence or absence of new 
protein synthesis (Figure 4.9C, -/+ CHX). Very little Psd1p was detected in aggregates in 
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mitochondria isolated from WT yeast grown at 30oC (Figure 4.9, C and D). In contrast, 
more Psd1p was aggregated when yme1Δ yeast were grown at this temperature, although 
the observed difference just failed to reach significance. Interestingly, when WT yeast were 
grown at 37oC, significantly more Psd1p, as well as additional integral inner membrane 
proteins, was present in aggregates. In contrast, the proportion of Psd1p detected in 
aggregates in yme1Δ mitochondria did not change following growth at this temperature. 
Combined, these results suggest that Yme1p has a routine role in monitoring the status of 
Psd1p (and other inner membrane proteins), that its capacity to perform this function is 
impaired and/or overwhelmed at elevated temperature, and that its absence shifts the 
mitochondrial proteostatic equilibrium under normal growth conditions to a stressed state.  
In the absence of new protein synthesis, the amount of Psd1p detected in aggregates 
did not change in mitochondria purified from WT and yme1Δ yeast, regardless of the 
incubation temperature (Figure 4.9, C and E). Since the proportion of Psd1p in aggregates 
was increased following growth of WT yeast at 37oC with continued protein synthesis 
(Figure 4.9D), this suggests that the stability of mature Psd1p is not overtly sensitive to 
elevated temperature, a conclusion that is reinforced by the yme1Δ-based results. Overall, 
our findings support the conclusion that Yme1p is an important determinant of WT Psd1p 
stability. Further, they underscore the difficulty of addressing this issue in yme1Δ yeast that 
express endogenous Psd1p and highlight the value of using the ts Psd1p allele as a tool to 
isolate the importance of Yme1p, and perhaps additional quality control proteases, in 
monitoring Psd1p fidelity. 
The removal of the Psd1ts precursor requires the sequential action of two 
mitochondrial proteases  
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The three COOH terminal containing Psd1ts fragments (f1, f2, and f3) that 
accumulated at 37oC in the absence of Yme1p required continued protein synthesis (Figure 
4.10A). This, combined with the simple fact that they by definition represent NH2-terminal 
truncations, indicates that they are products of the Psd1ts precursor. We initially 
hypothesized that as a serine protease, perhaps these fragments were generated by 
inappropriate Psd1ts self-proteolysis. To test this postulate, related isogenic yeast strains 
were established using HI-CRISPR that express a set amount of ts, S463A (cannot perform 
autocatalysis (Figure 4.2, B and D)), or ts-S463A Psd1p, in the presence or absence of 
Yme1p (Figure 4.10B). However, a ts mutant unable to perform autocatalysis (ts-S463A) 
still generated these fragments (Figure 4.10, C and D), indicating that a mitochondrial 
protease(s) is instead likely responsible for their production.  
With the goal of identifying the mitochondrial protease responsible for generating 
the Psd1ts precursor-derived fragments, we focused on Oma1p, a stress-activated 
mitochondrial protease that resides in the inner membrane (Baker et al., 2014; Bohovych, 
Donaldson, Christianson, Zahayko, & Khalimonchuk, 2014; Rainbolt, Lebeau, Puchades, 
& Wiseman, 2016; Rainbolt, Saunders, & Wiseman, 2015). Using HI-CRISPR, a series of 
related isogenic yeast strains were established that express a set amount of WT or ts Psd1p 
in the absence of Yme1p, Oma1p, or both (Figure 4.11A). With respect to its temperature-
dependent expression, maturation, and stability, WT Psd1p was insensitive to the loss of 
Oma1p (Figures 4.11B and 4.12, A, C, and D). Additionally, the absence of Oma1p, singly 
or in combination with Yme1p, did not change the thermosensitivity of Psd1ts (Figure 
4.11D) or its autocatalytic competency at the permissive temperature (Figure 4.11C). 
However, when Oma1p was missing, either by itself or together with Yme1p, the ts Psd1p 
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precursor accumulated at 37oC while two of the three COOH terminal containing Psd1ts 
fragments (f1 and f3) did not (Figure 4.11C, white arrowheads). Interestingly, post-
autocatalysis, the temperature-dependent stability of both Psd1ts subunits was unaffected 
by deletion of Oma1p (Figures 4.12, B-D). In sum, these results indicate that the 
degradation of a Psd1ts precursor unable to undergo autocatalysis depends on the 
cooperative and sequential action of two inner membrane proteases, Oma1p and Yme1p 
(Figure 4.11E). 
Oma1p-dependent generation of f1 and f3 is temperature-independent 
 When Yme1p is missing, the abundance of fragments f1 and f3 was increased for 
ts-S463A regardless of temperature (Figure 4.10D). This suggests that the ts mutations 
negatively impact the stability of the S463A-Psd1p precursor. Moreover, their 
accumulation implies that this Oma1p-dependent process can occur at both permissive and 
non-permissive temperatures, if in fact f1 and f3 from ts-S463A are produced downstream 
of Oma1p. To directly test this possibility, related isogenic yeast strains were established 
that express a set amount of ts, S463A, or ts-S463A Psd1p in the presence or absence of 
Yme1p (Figure 4.10B) or Oma1p (Figure 4.13, A and B). In Yme1p-replete yeast, fragment 
f1 was not detected for S463A and even though the amount of precursor was significantly 
lower following growth at 37oC (Figure 4.13C, white arrows), none of the COOH-terminal 
containing fragments accumulated (Figures 4.10D and 4.13C). When Yme1p is not 
expressed, fragments f1 and f3 produced from S463A accumulated at 37oC, providing 
evidence that they are degraded, but not produced, by Yme1p (Figure 4.13C, white 
arrowheads).  In the absence of Oma1p, fragment f1 was not detected and the amount of 
f3 was reduced for S463A. For ts-S463A, the absence of Yme1p increased the abundance 
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of the ts-S463A precursor and fragments f1 and f3 regardless of temperature. In contrast, 
in the absence of Oma1p, fragment f1 was not detected and the amount of f3 was reduced 
for ts-S463A, again at both incubation temperatures (Figure 4.13, B and C, white 
arrowheads). Thus, the Oma1p-dependent generation of fragments f1 and f3 does not 
require thermal stress since it can occur at both permissive and non-permissive 
temperatures (Figure 4.13D).  
The generation of f1 and f3 depends on Oma1p and requires structural perturbation 
of the Psd1p precursor 
 Finally, we wanted to determine if Oma1p activation alone is sufficient to drive the 
accumulation of f1 and f3 fragments from the S463A autocatalytic mutant (Figure 4.14A). 
Three types of stress have been shown to activate Oma1p in yeast (Bohovych et al., 2014): 
oxidative stress (hydrogen peroxide), membrane potential depolarization (CCCP), and 
membrane potential hyperpolarization (complex V inhibitor, oligomycin). As such, the 
ability of these agents to provoke the degradation of S463A, as well as WT and ts Psd1p, 
was determined at 22oC (S463A and ts Psd1p) or 30oC (WT Psd1p) (Figures 4.14, B-D). 
None of these Oma1p-activating agents either decreased the levels of the S463A precursor 
or increased the amounts of f1 and f3 fragments detected (Figure 4.14D). Collectively, 
these results indicate that activation of Oma1p by itself is insufficient to drive the 






Until recently, the LGST motif was the only structural motif known to be required 
for Psd1p autocatalysis. In this study we tested the hypothesis that mutations outside the 
conserved LGST motif that disturb generation of an autocatalytically competent tertiary 
structure would interfere with this essential self-activating event. To test this postulate, we 
initially focused on a previously established ts allele of PSD1 that has four missense 
mutations in the β subunit (Birner et al., 2003) and whose temperature sensitive mechanism 
had not been established. Indeed, here we demonstrated that the failure of the Psd1ts allele 
to rescue the ethanolamine auxotrophy of the psd1Δpsd2Δ strain at restrictive temperatures 
was due to a severe autocatalytic defect. Interestingly, the four missense mutations in Psd1ts 
cluster near a conserved histidine (His345) that, together with Asp210 and Ser463 of the 
LGST motif, we demonstrated forms a classic Ser-His-Asp catalytic triad. We thus 
speculate that the ts-associated mutations compromise the ability of the Psd1ts precursor to 
adopt a folded structure that properly juxtaposes the catalytic triad and enables 
autocatalysis. Our results confirm and extend conclusions derived from recent in vitro 
studies with membrane anchorless Plasmodium knowlesi Psd1 (Choi, Duraisingh, Marti, 
Ben Mamoun, & Voelker, 2015) by demonstrating that the initial serine protease activity 
of Psd1p is evolutionarily conserved and occurs in its native membrane environment in 
vivo.    
Post-autocatalysis, the missense mutations destabilize Psd1ts. Even when not 
exposed to heat, the four missense mutations in the ts β subunit weaken its non-covalent 
interaction with α. Further, fully processed Psd1ts that was allowed to accumulate at 
permissive temperature was rapidly degraded upon shifting to restrictive temperature. Both 
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in vivo and in isolated mitochondria, the stability of the α subunit of Psd1ts was more 
sensitive to heat than its β subunit. This is perhaps not surprising given its small size and 
the fact that it is anchored to the IMS side of the inner membrane through its non-covalent 
interaction with the β subunit, an association that is impaired for Psd1ts. To probe the 
relationship of α and β further, we artificially separated the two parts of Psd1p and 
expressed them in isolation or together. In the absence of only 38 amino acids that form 
the COOH terminus of the Psd1p precursor and which are destined to become the α subunit, 
Psd1β was hardly detected. This suggests that the ability of Psd1β to fold properly is 
dependent on its COOH terminus. Indeed, the importance of the α subunit for Psd1β folding 
and stability is evidenced by the fact that an IMS-directed α subunit increased the steady 
state abundance of Psd1β in trans. Given their co-dependence, it is tempting to speculate 
that Psd1p function could be tightly regulated by factors that decrease the stability of the 
interaction between the α and β subunits. Released α subunit would be quickly removed by 
an as yet unidentified mitochondrial protease and since it contains the essential pyruvoyl 
group, Psd1p activity would be abruptly turned off. 
 Our efforts to identify the mitochondrial protease(s) responsible for the efficient 
removal of Psd1ts at elevated temperatures revealed a striking difference that varied 
depending on the autocatalytic status of Psd1ts. Whereas post-autocatalysis, Yme1p activity 
alone is sufficient to clear aggregated ts β subunits, pre-autocatalysis, Oma1p activity 
generates two NH2-terminally truncated fragments that are then fully degraded by Yme1p. 
To our knowledge this is the first demonstration that two mitochondrial proteases function 
sequentially and cooperatively to degrade a terminally misfolded protein. The identity of 
the protease(s) working parallel to Yme1p and responsible for the rapid turnover of ts α at 
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elevated temperatures remains unresolved. An intriguing aspect of our findings is the 
requirement for Oma1p in resolving the misfolded Psd1ts precursor but not fully matured 
ts β given that both contain the same NH2-terminal regions. The basis for this is not 
immediately clear but may reflect the misfolded state obtained for an enzyme that has never 
properly folded versus one that has.  
Oma1p was originally identified using a ts allele of Oxa1p, a polytopic inner 
membrane protein (Kaser, Kambacheld, Kisters-Woike, & Langer, 2003). Similar to our 
study, it was shown that Oma1p lacks the ability to completely degrade Oxa1ts and instead 
generates proteolytic fragments which are normally resolved by the matrix-facing m-AAA 
protease. These results were taken as evidence that Oma1p has overlapping activity with 
the m-AAA protease, hence its name.  However, it is possible that, similar to our results 
with the Psd1ts precursor, in fact Oma1p functions upstream of the m-AAA protease to 
promote the degradation of Oxa1ts at non-permissive temperature.  If correct, then these 
results together raise the possibility that Oma1p has a general role in facilitating the 
disposal of proteins that are either unable to fold correctly or become misfolded because of 
stress. 
Given that Oma1p is activated by stress (Baker et al., 2014; Bohovych et al., 2014; 
Rainbolt et al., 2016; Rainbolt et al., 2015), we initially expected that its involvement in 
the turnover of the Psd1ts precursor would be temperature-dependent since 37oC is deemed 
a stressful temperature for yeast. However, the Oma1p-dependent accumulation of f1 and 
f3 fragments from ts-S463A Psd1p in the absence of Yme1p was as evident at 22oC as at 
37oC (Figures 4.10D and 4.13C). Thus, the temperature-dependent activation of Oma1p is 
not required to explain our results. Moreover, exogenous addition of Oma1p-activating 
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agents did not drive the accumulation of f1 and f3, or the diminution of ts-S463A (or WT 
and ts) precursor, at permissive temperature. When combined, these results suggest that 
Oma1p only detects Psd1p that has not undergone autocatalysis and that has been 
structurally perturbed, as in the case of unprocessed ts Psd1p at non-permissive temperature 
or the ts-S463A variant regardless of temperature. While the accumulation of f1 and f3 is 
Oma1p-dependent, it is unclear if Oma1p itself needs to be activated. Potentially, a small 
fraction of Oma1p is always basally active (Figure 4.14E, Model 1). According to this 
scenario, Oma1p can respond whenever a suitable substrate is encountered. Alternatively, 
perhaps the folding status of a substrate can itself trigger Oma1p activation (Figure 4.14E, 
Model 2).  In this case, any treatment that perturbs the structure of a potential substrate 
would have the innate capacity to stimulate a protease involved in its subsequent clearance. 
In mammals, OMA1 and YME1L work in parallel to regulate mitochondrial 
dynamics by processing long isoforms of OPA1, a dynamin-related GTPase that mediates 
inner membrane fusion, into short forms (Anand et al., 2014; Duvezin-Caubet et al., 2006; 
Ehses et al., 2009; Griparic, Kanazawa, & van der Bliek, 2007; Head, Griparic, Amiri, 
Gandre-Babbe, & van der Bliek, 2009; Song, Chen, Fiket, Alexander, & Chan, 2007). 
However, where and when these proteases cleave OPA1 and the functional consequences 
of their processing are different. Robust OXPHOS activity stimulates inner membrane 
fusion that requires YME1L mediated cleavage of OPA1 (Mishra, Carelli, Manfredi, & 
Chan, 2014). In contrast, when mitochondrial function is challenged by various types of 
stress, inner membrane fusion is inhibited by the complete processing of long OPA1 
isoforms at a different site by OMA1 (Anand et al., 2014; Baker et al., 2014; Griparic et 
al., 2007; Head et al., 2009; Korwitz et al., 2016). Intriguingly, following mitochondrial 
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depolarization, YME1L and OMA1 reciprocally degrade each other depending on cellular 
ATP levels (Rainbolt et al., 2016; Rainbolt et al., 2015). Cleavage of a long OPA1 isoform 
is performed by YME1L or OMA1 but not by both proteases (Anand et al., 2014; Ehses et 
al., 2009; Griparic et al., 2007; Head et al., 2009; Song et al., 2007). In contrast, we 
demonstrate here that Oma1p and Yme1p function sequentially to cooperatively degrade a 
common substrate that if left unresolved could compromise mitochondrial proteostasis. 
Thus, it would appear that depending on the substrate and/or cellular context, Yme1p and 
Oma1p can work alone, together, or antagonistically to ensure mitochondrial health. 
Our work extends an emerging story of an intimate relationship between 
mitochondrial phospholipid metabolism and the quality control machinery therein. 
Mitochondrial phospholipid synthesis requires transport pathways for lipid precursors and 
products across the aqueous IMS and leaflets of a bilayer. Ups1p and Ups2p, each in 
association with Mdm35p (Potting et al., 2010; Yasushi Tamura, Iijima, & Sesaki, 2010), 
contribute to the flux of PA and PS across the IMS by grabbing their lipid ligands in the 
outer membrane and transporting them to the inner membrane (Aaltonen et al., 2016; 
Connerth et al., 2012; Miyata, Watanabe, Tamura, Endo, & Kuge, 2016). In so doing, they 
help provide substrates for CL and PE synthesis. Interestingly, both Ups proteins have, for 
mitochondrial proteins, unusually short half-lives which is explained by their constitutive 
degradation by Yme1p and/or Atp23p (Potting et al., 2010). Previously, we demonstrated 
that Yme1p has a critical role in degrading certain Barth syndrome associated mutants of 
the monolyso-CL transacylase, tafazzin which retain some enzymatic activity but are prone 
to aggregation (Claypool, Whited, Srijumnong, Han, & Koehler, 2011). And in the present 
study we have documented a role for Yme1p in the biogenesis of Psd1p (the Psd1p 
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precursor accumulates in its absence), the turnover of an aggregation-prone allele of the β 
subunit post-autocatalysis, and the stability of endogenously expressed WT Psd1p. Further, 
we demonstrated that two proteases, Oma1p and Yme1p, work sequentially to remove a 
Psd1ts precursor that is unable to fully mature. A common feature for these lipid-related 
proteins is that they each work in or at the boundary between the hydrophilic surface and 
hydrophobic core of membranes, a denaturing environment. As such, we posit that the 
structurally destabilizing environment in which mitochondrial lipid metabolizing and 
transport proteins work has provoked the mitochondrial quality control machinery as a 
whole to evolve multiple means to monitor their fidelity.   
Very recently, a novel tumor suppressor, LACTB, was discovered that when 
overexpressed in certain cancer cell lines, reduces cell proliferation and increases cellular 
differentiation via a mechanism that is at least in part explained by a significant decrease 
in the levels of PISD, the mammalian Psd1p equivalent (Keckesova et al., 2017). 
Importantly, the decrease in PISD abundance is post-transcriptionally mediated and results 
in significant reductions in certain PE and lyso-PE species. However, the actual mechanism 
of PISD turnover was not determined. These findings clearly establish that the post-
transcriptional regulation of PISD is clinically relevant. Moving forward, it will be 
interesting to determine if some of the proteolytic pathways that we have identified in yeast 
using ts Psd1p are harnessed in certain physiological and/or pathophysiological contexts to 




MATERIALS AND METHODS 
Yeast strains and growth conditions  
All yeast strains used in this study were derived from GA74-1A (MATa, his3-11,15, leu2, 
ura3, trp1, ade8 [rho+, mit+]). psd1Δ (MATa, trp1, leu2, ura3, ade8, psd1Δ::HISMX6), 
psd1Δpsd2Δ (MATa, leu2, ura3, ade8, psd1Δ::TRP1, psd2Δ::HISMX6), and yme1Δ 
(MATa, trp1, leu2, ura3, ade8, yme1Δ::HISMX6) have been described previously (Hwang, 
Claypool, Leuenberger, Tienson, & Koehler, 2007; Onguka et al., 2015). 
psd1Δpsd2Δyme1Δ and psd1Δpsd2Δoma1Δ were generated by taking psd1Δpsd2Δ or 
psd1Δpsd2Δ with WT, ts, S463A, or ts-S463A PSD1 integrated into the Leu2 locus and 
using a CRISPR-cas9 gene block targeted against YME1 or OMA1. Specifically, yme1 and 
oma1 knockout were achieved using the Homology-Integrated CRISPR-Cas (HI-CRISPR) 
system (Bao et al., 2015). The plasmid pCRCT was a gift from Huimin Zhao (Addgene 
plasmid # 60621). The CRISPR-Cas9 target for YME1and OMA1 were selected using the 
yeastriction (yeastriction.tnw.tudelft.nl) (Mans et al., 2015) and Benchling 
(www.benchling.com) online CRISPR guide design tools. The CRISPR construct was 
designed to recognize residues 12-31 on the forward strand of YME1 and residues 118-137 
on the reverse strand of OMA1 (position 1 is the adenine of the AUG site). A 100bp 
homology repair template was designed to have 50bp homology arms on both sides 
flanking the Cas9 cutting site and incorporated an 8bp deletion so as to induce a frame shift 
mutation as described (Bao et al., 2015). psd1Δpsd2Δyme1Δoma1Δ strains were generated 
from the corresponding psd1Δpsd2Δyme1Δ strains. The spacer sequences (including the 
CRISPR-Cas9 target and the homology repair template) were ordered as gBlocks 
(Integrated DNA Technologies) and assembled into the pCRCT plasmid using the Golden 
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Gate assembly method (Engler, Gruetzner, Kandzia, & Marillonnet, 2009). OMA1 
disruption was confirmed by DNA sequencing.   
Yeast cells were grown in either rich lactate (1% yeast extract, 2% tryptone, 0.05% 
dextrose, 2% lactic acid, 3.4 mM CaCl2-2H20, 8.5 mM NaCl, 2.95 mM MgCl2-6H20, 7.35 
mM KH2P04, 18.7 mM NH4Cl, pH 5.5) or YPD (1% yeast extract, 2% peptone, 2% 
dextrose). To assess the function of the assorted Psd1p constructs and mutants, overnight 
cultures grown in YPD were spotted on synthetic complete dextrose plates in the absence 
or presence of 2 mM ethanolamine, and grown at 30oC or the indicated temperature. Steady 
state labeling of mitochondrial phospholipids was achieved by growing yeast for 24 hours 
at the indicated temperature in synthetic complete dextrose medium supplemented with 2 
mM choline and 2.5 μCi/ml 32Pi. To activate Oma1p, starter cultures grown in YPD at the 
permissive temperature were used to inoculate fresh tubes with 1 OD600/2ml YPD, which 
were spiked with nothing, 4 mM H2O2, 45 μM carbonyl cyanide m-chlorophenyl hydrazine, 
or 4 μM Oligomycin, and then incubated for 4 hours at 22oC (ts and S463A Psd1p) or 30 
oC (WT Psd1p), shaking at 220 rpm, prior to yeast protein extraction. 
Psd1p with a COOH-terminal 3XFLAG tag subcloned into pRS315 and pRS305 or 
harboring 6 COOH-terminal methionines and subcloned into pSP64 have been described 
(Onguka et al., 2015). The 6 Methionine residues added to the COOH-terminus allow 
detection of the α subunit post-autocatalysis in in vitro experiments while the addition of 
the 3XFLAG tag enables detection of the α subunit post-autocatalysis in vivo. PSD1 point 
mutations were generated by overlap extension (Ho, Hunt, Horton, Pullen, & Pease, 1989) 
using pRS305Psd3XFLAG as template. The temperature sensitive PSD1 allele (K356R, 
F397L, E429G, and M448T) was described previously (Birner et al., 2003) and assembled 
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here in the context of pRS305Psd3XFLAG by overlap extension.  Psd1β was generated by 
introducing a stop codon immediately after Gly462 and cloned into pRS315. To target the 
α subunit to the IMS, α-3XFLAG (starting at S463) was placed downstream of the first 64 
amino acids of cytochrome c1 but still under control of the PSD1 promoter by overlap 
extension and cloned into pRS316. IMS-α was subcloned into pCM189 to allow 
Doxycycline based repression. For inducible expression of IMS-α, starter cultures grown 
in SC-Leu-Ura + Ethanolamine (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 0.2% 
drop out mix complete, 2 mM ethanolamine, 2% dextrose) were used to inoculate fresh 
SC-Leu-Ura +Ethanolamine cultures, with or without 10 μg/ml doxycycline, which were 
grown overnight shaking at 220 rpm at 30oC. 
In organello import 
Radiolabeled precursors were produced using an SP6 Quick Coupled 
Transcription/Translation system (Promega) spiked with 35S Easy-Tag (PerkinElmer). 
Import of radiolabeled precursors utilized mitochondria isolated from D273-10B grown in 
rich lactate and was performed as described previously (Claypool et al., 2011; Onguka et 
al., 2015). Where indicated, valinomycin (1 μM) and carbonyl cyanide m-chlorophenyl 
hydrazine (5 μM) were added 5 min prior to precursor addition to collapse the 
mitochondrial proton motive force. Upon addition of radiolabeled precursor, import 
reactions were incubated at the designated temperature. At the indicated times, import was 
stopped with an equal volume of ice-cold BB7.4 (0.6 M sorbitol and 20 mM Hepes-KOH, 
pH 7.4), and mitochondria were re-isolated by spinning at 21,000 xg for 5 min at 4°C. 
100% of each time point and 5% of imported precursors were resolved on 15% SDS-PAGE 
gels and analyzed by phosphoimaging.  
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In vivo degradation experiments 
In vivo degradation experiments were performed as previously described (Claypool et al., 
2011). In brief, following growth at the permissive temperature, fresh tubes were 
inoculated with 6 OD600/3ml YPD and incubated for 5 minutes at the permissive 
temperature. Cycloheximide was added to a final concentration of 200 μg/ml to inhibit 
cytosolic protein synthesis and cultures incubated at the indicated temperature shaking at 
220 rpm. At each time point, 1 OD600 equivalents was transferred to a tube containing an 
equal volume of ice-cold 2X azide mix (20-mM NaN3 and 0.5 mg/ml BSA). Cells were 
collected (845 xg for 10 min at 4°C), the supernatant removed, and the pellets stored at -
80oC until all the time points were harvested. Proteins were extracted and SDS-PAGE and 
immunoblot performed as previously described (Claypool, Dickinson, Yoshida, Lencer, & 
Blumberg, 2002; Claypool, McCaffery, & Koehler, 2006).  
In organello heat shock assay  
Mitochondria isolated from yeast grown at permissive temperature were incubated at the 
indicated temperature for the designated times. Mitochondria were harvested by spinning 
at 21,000 xg for 5 min at 4°C and either further analyzed or resuspended in reducing sample 
buffer, boiled at 100oC for 5 minutes, resolved on custom made 10-16% SDS-PAGE gels, 
and analyzed by immunoblot.  
Immunoprecipitation 
Mitochondria (0.2 mg) were solubilized (2.5 mg/ml) for 30 min on ice with 20 mM Hepes-
KOH, pH 7.4, 20 mM imidazole, 10% glycerol, 100 mM NaCl, and 1 mM CaCl 2, 
supplemented with 1.5% (wt/vol) digitonin (Biosynth International, Inc.) and protease 
inhibitors (1 mM PMSF,10 μM leupeptin, and 2 μM pepstatin A). Clarified extracts 
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(21,000 xg for 30 min at 4°C) were diluted to 0.24% digitonin with lysis buffer base and 
incubated with 15μl anti FLAG Affinity Gel (Genscript) rotating at 4oC for 2hrs. Following 
a low speed spin, 0.1 mg of unbound material was transferred to a tube, TCA precipitated 
and processed for SDS-PAGE. The bound material was subjected to three 10 minute 
washes (1st: 0.1% Digitonin Wash buffer; 2nd: 0.1% Digitonin Wash buffer with 250 mM 
NaCl; 3rd: 0.1% Digitonin No Salt) and processed for SDS-PAGE. 
Antibodies 
Most antibodies used in this study were generated in our laboratory or in the laboratories 
of J. Schatz (University of Basel, Basel, Switzerland) or C. Koehler (UCLA) and have been 
described previously (Claypool et al., 2011; Hwang et al., 2007; Onguka et al., 2015; Y. 
Tamura et al., 2012; Whited, Baile, Currier, & Claypool, 2013). Other antibodies used were 
mouse anti-FLAG (clone M2, Sigma), horseradish peroxidase–conjugated (Fig. 2, 4, 5, 6D, 
6E, and 8D) or fluorescent-conjugated (Fig. 1C, 3B, 3F, 6B, 7A, 8B, 8E, 9C, 10A, 10D, 
11B, 11C, 12A,12D, 13C, and 14, B-D) secondary antibodies (Pierce).   
Miscellaneous 
Isolation of mitochondria, 1D BN-PAGE, detergent-based aggregation, phospholipid 
analyses, and immunoblotting were performed as previously described (Claypool, 
Boontheung, McCaffery, Loo, & Koehler, 2008; Claypool et al., 2006; Claypool et al., 
2011; Hwang et al., 2007; Onguka et al., 2015; Y. Tamura et al., 2012; Whited et al., 2013).  
Statistical comparisons were performed by t test or one-way analysis of variance 
(ANOVA) with Holm-Sidak pairwise comparison using SigmaPlot 11 software (Systat 
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Figure 4.1. Psd1ts has a temperature sensitive autocatalytic defect.  (A) Schematic of 
in vivo Psd1p constructs. The missense mutations in Psd1ts are indicated. MTS, 
mitochondrial targeting signal; TM, transmembrane domain. (B) The indicated strains pre-
cultured at 22oC were spotted onto synthetic complete dextrose (SCD) +/- 2mM 
ethanolamine and incubated at 22oC, 30oC, or 37oC for 3 days. (C) The α and β subunits of 
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Psd1p were analyzed by immunoblot in whole cell extracts isolated from cultures grown 
at the indicated temperature; Pic1p served as a loading control. β-α, Psd1p that has not 
performed autocatalysis. (D) After steady-state labeling with 32Pi in SCD +/- 2mM choline 
at the designated temperature, phospholipids were extracted from mitochondria isolated 
from the indicated strains and separated by TLC. The migration of phospholipids is 
indicated (PC, phosphatidylcholine; PI, phosphatidylinositol; CL, cardiolipin. (E) The 
relative abundance of PE was determined for each strain at each temperature and is 
expressed as a % of the total phospholipid for each strain at a given temperature (mean ± 
SEM, n = 6).  For the 22oC and 30oC samples, significant differences were determined by 
One Way ANOVA, with Holm–Sidak pairwise comparisons and are indicated; for the 37oC 
samples, the indicated significant differences were determined by Kruskal-Wallis One Way 
ANOVA on Ranks, with Tukey Test pairwise comparisons. n.s. = Not Significant.  (F) In 
vitro import of [35S] methionine-labeled WT, ts, or S463A Psd1p autocatalytic mutant into 
wild type mitochondria at 22oC, 30oC, and 37oC and in the presence (+ΔΨ) or absence (-
ΔΨ) of the proton motive force across the inner membrane. 5% of each precursor (-) and 






Figure 4.2. Identification of an (auto)catalytic triad in Psd1p. (A) Clustal Omega 
sequence alignment of Psd1p from the indicated species. Conserved potential bases (His 
residues; highlighted in green) and acids (Asp, Asn, Glu, and Gln; highlighted in purple) 
are indicated. The LGST motif is shown in yellow. The position of the four missense alleles 
present in Psd1ts are marked with red line. The determined base His345 and acid Asp210 
are designated with darker shading and green and purple lines. (B and D) psd1Δpsd2Δ 
yeast (-) and psd1Δpsd2Δ yeast transformed with the indicated Psd1p construct were grown 
overnight in SCD supplemented with 2 mM ethanolamine. The α and β subunits of Psd1p 
were detected in whole cell extracts by immunoblot; Pic1p served as a loading control. (C 
and E) psd1Δpsd2Δ yeast (-) and psd1Δpsd2Δ yeast transformed with the indicated Psd1p 
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Figure 4.3.  Psd1ts is unstable at non-permissive temperature. (A) In vivo degradation 
assay. (B) Whole cell extracts were isolated at the designated times following growth at 
the indicated temperature in the presence of cycloheximide (CHX). Samples were resolved 
by SDS-PAGE and immunoblotted as indicated. The α and β subunits of WT and ts Psd1p 
remaining at each timepoint at (C) 22oC, (D) 30oC, and (E) 37oC were quantified and 
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plotted as the % of protein remaining compared to t = 0. Mean ± SEM, n=4 * and # P≤0.05 
(Student's t-test). (F) Mitochondria isolated from psd1Δpsd2Δ expressing WT or ts Psd1p 
at 22oC were heat treated as indicated. Following incubation for the designated times, 
mitochondria were recovered and 50 μg resolved by SDS-PAGE and immunoblotted as 
indicated. The % of Psd1 β and α subunit remaining at each timepoint at (G) 30oC and (H) 




Figure 4.4. Association of α and β subunits is destabilized in Psd1ts. (A) Mitochondria 
isolated at permissive temperature from psd1Δpsd2Δ yeast expressing FLAG tagged WT 
or ts Psd1p, or untagged WT Psd1p, were solubilized with 1.5% (wt/vol) digitonin, 
separated by 6-16% BN-PAGE, and immunoblotted for the α or β subunit. Lower panels 
show immunoblots following SDS-PAGE. Red arrows and lines mark Psd1p complexes 
that are detected by antibodies against both the α and β subunits; gray lines designate ts 
Psd1p complexes that migrate faster and are only detected with the β subunit antisera; 
asterisks highlight background bands identified in psd1Δ mitochondrial extracts. (B) 
Following solubilization with 1.5% (wt/vol) digitonin, anti-FLAG resin was used to 
immunoprecipitate the FLAG tagged α subunit and the presence of co-purified β 
determined by immunoblot; Tom70p and Pic1p served as controls. SM, starting material; 
B, bound material; FT, non-binding flow thru. (C) The percentage of each subunit detected 
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in the non-binding flow thru was determined as follows: FT/SM x 100, where FT is the 
volume of Psd1p α or β subunit detected in the flow thru and SM is the volume associated 
with the corresponding starting material. Mean ± SEM, n=3. Student's t-test were used to 
compare the α and β subunits. * P<0.001 versus FLAG tagged WT Psd1p (One-way 




Figure 4.5. Pre-autocatalysis, Psd1 β requires α for stability. (A) Schematic of in vivo 
constructs to individually express the β and α subunits. The stop-transfer signal of 
cytochrome c1 is indicated in pink. (B) Whole cell extracts from psd1Δpsd2Δ yeast 
transformed as indicated were resolved by SDS-PAGE and immunoblotted for the α and β 
subunits; Tom70p served as a loading control. * highlight IMS-targeted α subunit that has 
not been fully processed. (C) In parallel, the same yeast were spotted onto SC-Leu-Ura +/- 
2mM ethanolamine and incubated at 30oC for 3 days. (D) In vitro import of [35S] 
methionine-labeled WT or Psd1 β into wild type mitochondria at 30oC in the presence 
(+ΔΨ) or absence (-ΔΨ) of the proton motive force. 5% of each precursor (-) and 100% of 
every time point were analyzed. P, precursor; I, import intermediate; m, mature β subunit. 
(E) psd1Δpsd2Δ expressing Psd1β were transformed further as indicated. (F) Immunoblots 
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for the α and β subunits in the indicated whole cell extracts; Tom70p served as a loading 
control. * highlight IMS-targeted α subunit that has not been fully processed. (G) In 
parallel, the same yeast were spotted onto SC-Leu-Ura +/- 2mM ethanolamine and 
incubated at 30oC for 3 days. (H) Following solubilization of the designated mitochondria 
with 1.5% (wt/vol) digitonin, anti-FLAG resin was used to immunoprecipitate the FLAG 
tagged α subunit and the presence of co-purified β determined by immunoblot; Tom70p 
and Pic1p served as controls. SM, starting material; B, bound material; FT, non-binding 
flow thru. A background band detected in each Bound lane detected in the FLAG 
immunoblot is marked with a blue circle. (I) To determine digitonin solubilization 
efficiency, 25 μg of starting material (SM) and non-extracted (NE) pellet post-digitonin 
solubilization was resolved by SDS-PAGE and immunoblotted as indicated. A decreased 
signal intensity in the NE lanes (red arrowheads) relative to the corresponding SM lanes 
reflects the fraction of each protein that was extracted by digitonin. The percentage of Psd1 
β not extracted by digitonin is shown below the bottom panel and was determined as 
follows: NE/SM x 100, where NE is the volume of Psd1 β subunit detected in NE and SM 
is the volume associated with the corresponding starting material. Mean ± SEM, n=3 





Figure 4.6. Three COOH terminal containing Psd1ts fragments accumulate in the 
absence of Yme1p. (A) Schematic for generating strains expressing a set amount of WT 
or ts Psd1p in the presence or absence of Yme1p. (B) Immunoblots for Yme1p and the α 
and β subunits of WT and ts Psd1p in the indicated whole cell extracts from yeast grown 
at listed temperature; Pic1p served as a loading control. β-α, Psd1p that has not performed 
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autocatalysis. f1, f2, and f3, COOH terminal containing Psd1ts fragments. (C) The indicated 
strains pre-cultured at 22oC were spotted onto SCD +/- 2mM ethanolamine and incubated 
at 22oC, 30oC, or 37oC for 3 days. (D) Mitochondria isolated at permissive temperature 
from psd1Δpsd2Δ yeast expressing FLAG tagged WT or ts Psd1p, or untagged WT Psd1p, 
in presence or absence of Yme1p, were solubilized with 1.5% (wt/vol) digitonin, separated 
by 6-16% BN-PAGE, and immunoblotted for the α subunit or β subunit. Red arrows and 
lines mark Psd1p complexes that are detected by antibodies against both the α and β 
subunits; gray lines designate ts Psd1p complexes that migrate faster and are only detected 
with the β subunit antisera; asterisks highlight background bands identified in Δpsd1 
mitochondrial extracts. (E) Following solubilization with 1.5% (wt/vol) digitonin, anti-
FLAG resin was used to immunoprecipitate the FLAG tagged α subunit and the presence 
of co-purified β determined by immunoblot; Tom70p, Atp2p, and Pic1p served as controls. 
SM, starting material; B, bound material; FT, non-binding flow thru. (F) The percentage 
of each subunit detected in the non-binding flow thru was determined as follows: FT/SM 
x 100, where FT is the volume of Psd1p α or β subunit detected in the flow thru and SM is 
the volume associated with the corresponding starting material.  Mean ± SEM, n=3 
Student's t-test were used to compare the α and β subunits. * P<0.001 versus FLAG tagged 




Figure 4.7. Yme1p is responsible for the rapid turnover of ts β but not ts α. (A) In vivo 
degradation assay. Whole cell extracts were isolated at the designated times following 
growth at the indicated temperature in the presence of CHX. Samples were resolved by 
SDS-PAGE and immunoblotted as indicated.  (B) The % of α and β subunits remaining 
after 24hrs at 37oC for WT and ts Psd1p in the presence or absence of Yme1p was 
quantified. Mean ± SEM, n=4 * P≤0.05 (Student's t-test). (C) The % of α and β subunits 
remaining for WT and ts Psd1p at each timepoint +/- Yme1p was quantified. Mean ± SEM, 




Figure 4.8. ts β subunit aggregates require Yme1p for their removal. (A) Schematic 
for assays performed in isolated mitochondria heat treated or not. (B) Mitochondria were 
isolated from the indicated yeast strains grown at 22oC. Following incubation for the 
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designated times at 37oC, mitochondria were recovered and 50 μg resolved by SDS-PAGE 
and immunoblotted as indicated. (C) The % of α and β subunits remaining for WT and ts 
Psd1p at each timepoint +/- Yme1p was quantified. Mean ± SEM, n=3. (D) Mitochondria 
incubated for the designated times at 37oC were solubilized with 1.5% (wt/vol) digitonin, 
the FLAG tagged α subunit captured with anti-FLAG resin, and the presence of co-purified 
β determined by immunoblot; Tom70p and Atp2p served as controls. SM, starting material; 
B, bound material; FT, non-binding flow through. (E) Mitochondria were kept on ice or 
incubated at 37oC for 1hr prior to performing a sequential detergent solubilization assay to 
detect protein aggregation.  Fractions were resolved by SDS–PAGE and immunoblotted as 
indicated. (F and G) The percentage of WT and ts β subunit (F) and α subunit (G) in TX-
100-insoluble aggregates was determined. Mean ± SEM; n = 3 (H) When shifted to high 
temperatures, the β subunit of Psd1ts forms aggregates that are resolved by Yme1p. The α 
subunit is not included in the ts β subunit aggregates and is rapidly degraded by an 




Figure 4.9. Evidence that Yme1p is important for endogenous Psd1p fidelity. (A) 
Mitochondria (50µg) from WT and yme1Δ yeast grown at the indicated temperature were 
immunoblotted as designated. (B) Densitometry analyses of protein steady state levels 
199 
 
from mitochondrial extracts from Figure 9A. Expression relative to WT at 30oC ± SEM n 
= 6 for Psd1p and Aac2p and n = 3 for Pic1p. Significant differences were determined by 
Student's t-test and are indicated; if Normality or Equal Variance tests failed, significant 
differences were instead determined by Mann-Whitney Rank Sum Test (C) Mitochondria 
were isolated from WT and yme1Δ yeast grown at the indicated temperature in the absence 
(left panels) or presence of CHX for 24hrs (right panels) and protein aggregation 
determined using the sequential detergent solubilization assay. Fractions were resolved by 
SDS–PAGE and immunoblotted as indicated. (D) The percentage of Psd1p β subunit, 
Pic1p, and Aac2p in TX-100-insoluble aggregates following growth of WT and yme1Δ 
yeast at 30oC or 37oC in absence of CHX was determined. Mean ± SEM; n = 5 (E) The 
percentage of Psd1p β subunit, Pic1p, and Aac2p in TX-100-insoluble aggregates 
following growth of WT and yme1Δ yeast for 24hrs at 30oC or 37oC in presence of CHX 
was determined. Mean ± SEM; n = 5 Significant differences in D and E were determined 
by One Way ANOVA, with Holm–Sidak pairwise comparisons and are indicated; if 
Normality or Equal Variance tests failed, significant differences were instead determined 
by Kruskal-Wallis One Way ANOVA on Ranks, with Tukey Test pairwise comparisons. 




Figure 4.10. The three COOH terminal containing Psd1ts fragments are not generated 
by aberrant self-proteolysis. (A) Immunoblots for Yme1p and the α and β subunits of 
WT and ts Psd1p in the indicated whole cell extracts from yeast grown at 37oC for 24hrs 
with or without CHX; Pic1p served as a loading control. (B) Schematic for generating 
strains expressing a set amount of ts, S463A, or ts-S463A Psd1p in the presence or absence 
of Yme1p. (C) The indicated strains pre-cultured at 22oC were spotted onto SCD +/- 2mM 
ethanolamine and incubated at 22oC or 37oC for 5 days. (D) Immunoblots for Yme1p and 
the α and β subunits of  ts, S463A, and ts-S463A Psd1p in the indicated whole cell extracts 
from yeast grown at listed temperature; Pic1p served as a loading control. β-α, Psd1p that 




Figure 4.11. Oma1p and Yme1p work sequentially to degrade the Psdts precursor. (A) 
Schematic for generating strains expressing a set amount of WT or ts Psd1p in the presence 
or absence of Oma1p and/or Yme1p. (B and C) Immunoblots for Yme1p and the α and β 
subunits of (B) WT Psd1p or (C) ts Psd1p in whole cell extracts from the indicated yeast 
grown at listed temperature; Pic1p served as a loading control. (D) The indicated strains 
pre-cultured at 22oC were spotted onto SCD +/- 2mM ethanolamine and incubated at 22oC, 
30oC, or 37oC. (E) When Psd1ts is unable to adopt an autocatalytically competent tertiary 
structure at restrictive temperature, Oma1p generates two COOH-terminal containing 
fragments that are then completely degraded by Yme1p. 
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Figure 4.12. Oma1p is not required for the degradation of either ts subunit post-
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autocatalysis. (A and B) In vivo degradation assay. Whole cell extracts from yeast 
expressing (A) WT Psd1p or (B) ts Psd1p were isolated at the designated times following 
growth at the indicated temperature in the presence of CHX. Samples were resolved by 
SDS-PAGE and immunoblotted as indicated. (C) The % of α and β subunits remaining for 
WT and ts Psd1p at each time point in the absence of Oma1p or the combined absence of 
Oma1p and Yme1p was quantified. Mean ± SEM, n=4  # P≤0.05 (Student's t-test). (D) 
The % of α and β subunits remaining after 24hrs at 37oC for WT and ts Psd1p in the 
presence or absence of Oma1p and/or Yme1p was quantified. Mean ± SEM, n=4 * P≤0.05 




Figure 4.13. Oma1p-dependent generation of f1 and f3 can occur at 22oC. (A) 
Schematic for generating strains expressing a set amount of ts, S463A, or ts-S463A Psd1p 
in the presence or absence of Oma1p. (B) The indicated strains pre-cultured at 22oC were 
spotted onto SCD +/- 2mM ethanolamine and incubated at 22oC or 37oC for 5 days. (C) 
Immunoblots for Yme1p and the α and β subunits of ts, S463A, and ts-S463A Psd1p in the 
indicated whole cell extracts from yeast grown at listed temperature; Pic1p served as a 
loading control. β-α, Psd1p that has not performed autocatalysis. f1, f2, and f3, COOH 
terminal containing Psd1p fragments. (D) The Oma1p-dependent accumulation of f1 and 
f3 fragments from ts-S463A Psd1p occurs at both 22oC and 37oC. 
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Figure 4.14. Oma1p activation is not sufficient to drive the accumulation of f1 and f3. 
(A) Can known Oma1p-activating agents result in the accumulation of f1 and f3 fragments 
from the autocatalytic mutant S463A Psd1p? (B-D) Immunoblots for Yme1p and the α and 
β subunits of (B) WT, (C) ts, and (D) S463A Psd1p in whole cell extracts from yeast grown 
at 22oC (ts and S463A) or 30oC (WT Psd1p) in the absence or presence of 4 mM H2O2, 45 
μM CCCP, or 4 μM Oligomycin for 4hrs; Pic1p served as a loading control. β-α, Psd1p 
that has not performed autocatalysis. f1, f2, and f3, COOH terminal containing Psd1p 
fragments. (E) Two possible models that explain the generation of f1 and f3 from misfolded 
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Psd1p precursor. According to Model 1, some fraction of Oma1p is always basally active 
and thus available to degrade misfolded Psd1p precursor in the absence of any overt 
mitochondrial stress. In Model 2, the misfolded Psd1p precursor itself is the signal that 
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